Medicare Program; Prospective Payment System for Hospital Outpatient Services; Correction

Federal RegisterJun 30, 1999

Ask Donna

What actually matters in this document.

Text

SUMMARY: This document corrects technical and typographic errors that

appeared in the proposed rule published in the Federal Register on

September 8, 1998 entitled ``Medicare Program; Prospective Payment

System for Hospital Outpatient Services.

FOR FURTHER INFORMATION CONTACT:

Janet Wellham, (410) 786-4510 (for general information).

Kitty Ahern, (410) 786-4515 (for information related to the

classification of services into ambulatory payment classification (APC)

groups).

Suzanne Letsch (410) 786-4558 (for information related to volume

control measures and updates).

Janet Samen (410) 789-9161 (for information on the application of APCs

to community health centers).

SUPPLEMENTARY INFORMATION:

Background

In FR Doc. 98-23383 of September 8, 1998 (63 FR 47551), we

published a proposed rule that reflected a number of technical errors,

resulting in inconsistencies between the proposed policies and the

associated numerical values. Specifically, the numerical values in the

proposed rule reflected incorrect data and data programming. This

document sets forth corrected numerical values.

The problems in the data and data programming are a direct result

of the frequent modifications to our databases during the initial

development of the model prospective payment system and the changes we

made during the development of the proposed rule to reflect the final

legislative provision enacted on August 5, 1997 in the Balanced Budget

Act of 1997 (BBA 1997), Public Law 105-33. We have corrected our

databases and our data programming, and this document corrects the

numerical values published in the September 8, 1998 proposed rule.

Correcting the data errors does not mean that the proposed policies

themselves need to be revised. Correcting the data changes the impacts

of the proposed policies to a very limited extent, but this document

does not revise any of the policies reflected in the September 8, 1998

proposed rule.

Accordingly, we have recalculated the current payment, total

services (total units) and corrected relative weights, proposed payment

rates, national unadjusted coinsurance, minimum unadjusted coinsurance,

and service-mix index that were published on September 8, 1998.

The service-mix indices previously published in the proposed rule

are significantly different from the service-mix index published in

this correction notice (in Addendum I) because the ambulatory payment

classification (APC) relative weights used to calculate the service mix

published in the proposed rule were scaled using a factor ``for a high-

level clinic visit for cardiovascular services (that is, APC 91356)

rather than a mid-level clinic visit for cardiovascular services,

identified as APC 91336.'' In addition, the service-mix index published

in this correction notice incorporates the discount policy applied to

multiple surgeries. However, the relative differences among hospitals

did not change substantially between the proposed and corrected

service-mix indices.

These data corrections required that we also correct our

simulations of current payment, costs, and total units, leading to

slight differences from the September 8, 1998 published version. Fully

modeling proposed payment after accounting for data corrections, we

calculated a new calendar year (CY) 1996 conversion factor of $46.87,

which is slightly higher than the published CY 1996 conversion factor

of $46.32. In addition to the data corrections mentioned above, we also

made a correction in the computation of the conversion factor to

appropriately account for wage index adjustments in proposed payments.

The adjusted CY 1999 conversion factor is $51.42.

Corrected simulations of costs and total units impacted the results

of the regression analyses that we use in conjunction with payment

simulations to determine whether the payment system should include

adjustments for specific classes of hospitals. However, the results do

not change our conclusion hat no adjustments be proposed at this time.

These corrections require revisions to the impact tables and they

also affect entries contained in Addendum A, Addendum B, Addendum C,

Addendum D, and Addendum G. Addendum J, Addendum K, and Addendum L are

revised to reflect the correct version of the wage index. Because of

the many corrections to these ``materials, we are reprinting portions

of the impact analysis and the entire impact tables and agenda, below,

in this notice.

The September 8, 1998 proposed rule also contained other technical

and typographic errors. Errors related to the incorrect assignment of

status indicators to certain CPT codes listed in Addendum B are

corrected and reflected in the revised Addendum B printed in full

below.

In FR Doc. 98-23383 of September 8, 1998, make the following

corrections to the preamble, regulations text and addenda:

Correction of Errors in the Preamble

1. On pages 47564 through 47565, the table titled ``Packaged

Services by Revenue Center'' is corrected to read as follows:

Packaged Services by Revenue Center

------------------------------------------------------------------------

------------------------------------------------------------------------

SURGERY

------------------------------------------------------------------------

250............................... PHARMACY

251............................... GENERIC

252............................... NONGENERIC

257............................... NONPRESCRIPTION DRUGS

258............................... IV SOLUTIONS

259............................... OTHER PHARMACY

270............................... M&S SUPPLIES

271............................... NONSTERILE SUPPLIES

272............................... STERILE SUPPLIES

276............................... INTRAOCULAR LENS

279............................... OTHER M&S SUPPLIES

370............................... ANESTHESIA

379............................... OTHER ANESTHESIA

380............................... BLOOD, GENERAL CLASS

381............................... PACKED RED CELLS

382............................... WHOLE BLOOD

383............................... PLASMA

384............................... PLATELETS

385............................... LEUCOCYTES

386............................... OTHER COMPONENTS

387............................... OTHER DERIVATIVES

389............................... OTHER BLOOD

390............................... BLOOD STORAGE AND PROCESSING

391............................... BLOOD ADMINISTRATION

399............................... OTHER BLOOD PROC/STORAGE

700............................... CAST ROOM

709............................... OTHER CAST ROOM

710............................... RECOVERY ROOM

719............................... OTHER RECOVERY ROOM

720............................... LABOR ROOM

721............................... LABOR

723............................... CIRCUMCISION

762............................... OBSERVATION ROOM

810............................... ORGAN ACQUISITION

[[Page 35259]]

819............................... OTHER ORGAN ACQUISITION

890............................... OTHER DONOR BANK

891............................... BONE

892............................... ORGAN

893............................... SKIN

899............................... OTHER DONOR BANK, OTHER

------------------------------------------------------------------------

MEDICAL VISIT

------------------------------------------------------------------------

250............................... PHARMACY

251............................... GENERIC

252............................... NONGENERIC

257............................... NONPRESCRIPTION DRUGS

258............................... IV SOLUTIONS

259............................... OTHER PHARMACY

270............................... M&S SUPPLIES

271............................... NONSTERILE SUPPLIES

272............................... STERILE SUPPLIES

279............................... OTHER M&S SUPPLIES

380............................... BLOOD, GENERAL CLASS

381............................... PACKED RED CELLS

382............................... WHOLE BLOOD

383............................... PLASMA

384............................... PLATELETS

385............................... LEUCOCYTES

386............................... OTHER COMPONENTS

387............................... OTHER DERIVATIVES

389............................... OTHER BLOOD

390............................... BLOOD STORAGE AND PROCESSING

391............................... BLOOD ADMINISTRATION

399............................... OTHER BLOOD PROC/STORAGE

700............................... CAST ROOM

709............................... OTHER CAST ROOM

762............................... OBSERVATION ROOM

------------------------------------------------------------------------

OTHER DIAGNOSTIC (BLENDED SERVICES)

------------------------------------------------------------------------

254............................... PHARMACY INCIDENT TO OTHER

DIAGNOSTIC

372............................... ANESTHESIA INCIDENT TO OTHER

DIAGNOSTIC

380............................... BLOOD, GENERAL CLASS

381............................... PACKED RED CELLS

382............................... WHOLE BLOOD

383............................... PLASMA

384............................... PLATELETS

385............................... LEUCOCYTES

386............................... OTHER COMPONENTS

397............................... OTHER DERIVATIVES

389............................... OTHER BLOOD

390............................... BLOOD STORAGE AND PROCESSING

391............................... BLOOD ADMINISTRATION

399............................... OTHER BLOOD PROC/STORAGE

622............................... SUPPLIES INCIDENT TO OTHER

DIAGNOSTIC

710............................... RECOVERY ROOM

719............................... OTHER RECOVERY ROOM

762............................... OBSERVATION ROOM

------------------------------------------------------------------------

RADIOLOGY

------------------------------------------------------------------------

255............................... PHARMACY INCIDENT TO RADIOLOGY

371............................... ANESTHESIA INCIDENT TO RADIOLOGY

380............................... BLOOD, GENERAL CLASS

381............................... PACKED RED CELLS

382............................... WHOLE BLOOD

383............................... PLASMA

384............................... PLATELETS

385............................... LEUCOCYTES

386............................... OTHER COMPONENTS

387............................... OTHER DERIVATIVES

389............................... OTHER BLOOD

390............................... BLOOD STORAGE AND PROCESSING

391............................... BLOOD ADMINISTRATION

399............................... OTHER BLOOD PROC/STORAGE

621............................... SUPPLIES INCIDENT TO RADIOLOGY

710............................... RECOVERY ROOM

719............................... OTHER RECOVERY ROOM

762............................... OBSERVATION ROOM

------------------------------------------------------------------------

ALL OTHER APC GROUPS

------------------------------------------------------------------------

250............................... PHARMACY

251............................... GENERIC

252............................... NONGENERIC

257............................... NONPRESCRIPTION DRUGS

258............................... IV SOLUTIONS

259............................... OTHER PHARMACY

270............................... M&S SUPPLIES

271............................... NONSTERILE SUPPLIES

272............................... STERILE SUPPLIES

279............................... OTHER M&S SUPPLIES

380............................... BLOOD, GENERAL CLASS

381............................... PACKED RED CELLS

382............................... WHOLE BLOOD

383............................... PLASMA

384............................... PLATELETS

385............................... LEUCOCYTES

386............................... OTHER COMPONENTS

387............................... OTHER DERIVATIVES

389............................... OTHER BLOOD

390............................... BLOOD STORAGE AND PROCESSING

391............................... BLOOD ADMINISTRATION

399............................... OTHER BLOOD PROC/STORAGE

762............................... OBSERVATION ROOM

------------------------------------------------------------------------

2. On page 47568, column two, line 16, the figure ``$208.25'' is

corrected to read ``$206.71''.

3. On page 47572, column one, last paragraph, the date and Federal

Register citation are corrected to read as follows: August 29, 1997 (62

FR 45984).

4. On page 47573, column three, line nine, ``$46.32'' is corrected

to read ``$46.87''.

5. On page 47573, column three, line 12, ``1.0939'' is corrected to

read ``1.097''.

6. On page 47573, column three, line 24, the text beginning with

the sentence ``In estimating the update factor, HCFA's Office of the

Actuary assumed * * *'' through the phrase ending ``Medicare absorbing

this impact'' in line 44 is removed.

7. On page 47573, column three, line 46, ``$50.67'' is corrected to

read ``$51.42''.

8. On page 47574, column two, in section 2(a)(ii), line four,

``29.2'' is corrected to read ``13.0''.

9. On page 47576, column two, line 26, ``1999'' is corrected to

read ``1998''.

10. On page 47576, column two, line 28, the Federal Register title,

date, and citation are corrected to read as follows: ``Changes to the

Hospital Inpatient Prospective Payment Systems and Fiscal Year 1998

Rates (BPD-878-FC) published in the Federal Register on August 29, 1997

(62 FR 45995)''.

11. On page 47577, column one, paragraph two, line 39, ``1996'' is

corrected to read ``1998''.

12. On page 47577, column two, last paragraph, line nine, ``$105''

is corrected to read ``$120''.

13. On page 47578, column two, second full paragraph, line four,

the following new sentence is added to read as follows: ``The edits

referred to in this section were not used in the development of the

weights or the impact analysis described in this proposed rule.''

14. On page 47580, column one, First line, the words ``level 1''

are added after the words ``hospitals with'' and before the word

``trauma''.

15. On page 47580, column one, line two, the sentence beginning

``These costs were * * *'' is removed and is replaced with the

following: ``These costs were 200 percent or more higher than the

average cost per unit for all hospitals.''

16. On page 47580, column one, last paragraph, line one, ``83'' is

corrected to read ``96''.

17. On page 47580, column one, last paragraph, line three, ``51''

is corrected to read ``46''.

18. On page 47580, column one, last paragraph, line six, ``32'' is

corrected to read ``50''.

19. On page 47580, column two, line five, ``5,419'' is corrected to

read ``5,335''.

20. On page 47580, column two, second full paragraph, line 14, the

words ``level 1'' are added before the words ``trauma unit''.

21. On page 47580, column two, last paragraph, line four, the

sentence beginning ``We also calculated * * *'' is removed and is

replaced with the following: ``This service mix is ``discounted'' to

reflect the reduced weight for additional surgical procedures performed

at the same time, which is consistent with the proposed payment

system.''

22. On page 47580, column two, last paragraph, line 10, the

sentence beginning ``The national average * * *'' is removed and is

replaced with the following: ``The national average service mix

discounted for multiple procedures is 2.05.''

[[Page 35260]]

23. On page 47580, column two, last paragraph, last line, remove

text from the sentence beginning ``The differences between * * *''

through line seven in column three.

24. On page 47580, column three, first full paragraph, line 13,

``0.68'' is corrected to read ``0.76''.

25. On page 47580, column three, first full paragraph, line 17,

``6.8 percent'' is corrected to read ``7.6 percent''.

26. On page 47580, column three, paragraph two, line 25, ``7.5

percent'' is corrected to read ``8.9 percent''.

27. On page 47580, column three, the third full paragraph through

page 47581, column one, line 10, is removed and is replaced with the

following: ``While the regression analysis shows less than a

proportional relationship between the service mix and the cost per

unit, the difference is relatively small. The coefficient of service

mix ranged from 0.76 to 0.92 over the regression models we examined. We

will continue to monitor the method of basing payments on median APC

costs to ascertain whether it is representative of both high-weighted

and low-weighted procedures.''

28. On page 47581, column one, first full paragraph, line nine,

``0.51 to 0.68'' is corrected to read ``0.40 to 0.58.''

29. On page 47581, column one, first full paragraph, lines 10 to

11, ``50 and 70 percent.'' is corrected to read ``40 and 60 percent.''

30. On page 47581, column one, first full paragraph, line 29, the

sentence beginning ``The explanatory regression * * *'' is removed.

31. On page 47581, column two, first full paragraph, line 10, the

word ``not'' is added before ``significant''.

32. On page 47581, column two, first full paragraph, line 13, ``4.5

percent [calculated (eDSHP*0.11-1)*100]'' is corrected read

``1.6 percent [calculated (eDSHP*0.04-1)*100]''.

33. On page 47581, column two, first full paragraph, line 16, the

text beginning with ``Teaching intensity * * *'' through line 21 ending

with ``services.'' is removed and is replaced with the following: ``The

extremely small percentage difference in costs reflects the lack of

significance observed for the disproportionate share variable. In most

regression specifications, the teaching intensity variables were

positive, significant (p0.14-1)*100].''

35. On page 47581, column three, first full paragraph, line eight,

``8 percent'' is corrected to read ``12 percent''.

36. On page 47581, column three, first full paragraph, line nine,

``other'' is added before ``urban''.

37. On page 47581, column three, second full paragraph, line two,

``(long-term care, children's, and psychiatric)'' is corrected to read

``(long-term care and children's)''.

38. On page 47581, column three, second full paragraph, line six,

``Cancer, children's and long-term care'' is removed and is replaced

with ``These''.

39. On pages 47581 through 47582 and continued on page 47585,

through line five of the first full paragraph in column two, the text

in the section titled ``Estimated Payments'' is removed and is replaced

with the following:

The appropriateness of potential payment adjustments must be based

on both cost effects estimated by regression analysis and other factors

including simulated payment impacts. We simulated the impact of the

proposed system on hospitals by calculating the percentage difference

between payments made under current law and payments under the proposed

system (column 3). Section X. contains a more complete table that

considers the impact of proposed payments on additional classes of

hospitals, including TEFRA and cancer hospitals. Although Column 3

represents the net effect of the new PPS on hospitals, we though it was

necessary to show the impacts on hospitals of simply changing the

payment system without including the effects of the overall reduced

payment to hospitals because the PPS system is not budget neutral to

current payment. To reiterate, the conversion factor is set by summing

Medicare payments under the current system and beneficiary copayment

under the new system and dividing by the sum of the relative weights.

Beneficiary copayments under the new system will reduce overall

payments to most hospitals because 20 percent of the median group

charges is less than 20 percent of actual charges. Therefore, we

simulated the impacts as though the conversion factor were set as if

the system were to be budget neutral. Column 4 demonstrates the

distributional impacts resulting from implementing the new system after

eliminating the overall reduction in payment most hospitals will

experience due to the effect of the methodology used to set the

conversion factor. We believe the column 4 percentage differences are

what we should examine since any adjustment we would consider should

correct for inequities caused by moving to a PPS (not the legislated

reduction in total payment). Therefore, we based our decision about

adjustments on these percentage differences rather than percentages

combining the PPS and the overall reduction in coinsurance amounts

required by law. We also estimated payment-to-cost ratios associated

with the new payment methods and the percent change in total Medicare

payments. All simulations used a labor share of 60 percent. The table

below shows the results of two simulations. The first contains only the

wage index adjustment to the APC rates. The second also includes the

threshold adjustment for teaching intensity discussed above.

Based on our analyses, we are not proposing to make adjustments to

the outpatient payment rates for disproportionate share patient

percentage and teaching intensity and rural location for the following

reasons.

1. Estimated effects of disproportionate share patient percentage

on costs were small and most often not statistically significant.

2. After removing the copay effect, most teaching hospitals gain

under the proposed system payments relative to current law. Although

teaching hospitals with a large number of residents relative to

outpatient and inpatient utilization demonstrate slightly higher costs,

targeting these hospitals with a small adjustment does not greatly

improve their payment

[[Page 35261]]

impacts. These impacts should also be evaluated in terms of the overall

effect on Medicare payments because on average, outpatient services

account for 10 percent of hospitals' Medicare payments. For example,

the associated reduction of total Medicare payments for major teaching

hospitals would be about 1 percent.

3. With the teaching adjustment we considered, estimated overall

payment reductions for rural hospitals would be 7.9 percent under the

proposed system, rather than 7.4 percent. These hospitals also receive

a greater percent of their Medicare income (14.7 percent) from

providing outpatient services. Similarly, payment reductions for low-

volume rural hospitals would be 17.8 percent of current payments,

rather than 17.4 percent, and these hospitals also earn a greater

percentage of their Medicare income (18.4 percent) from providing

outpatient services. Because of these potential shifts in payments, any

adjustment should be based on stronger analytic results then those

found with the current data.

4. We also believe the issue of payment adjustments should be

reexamined using data from initial years of the implemented system

because current cost calculations and relationships among key factors

and costs probably are affected by variation in coding patterns.

5. HCFA is working towards standardizing payment across all sites

of service. Fewer adjustments to the outpatient PPS would allow HCFA to

move ahead more quickly with this approach.

6. We believe that we should monitor the impact of basing APC

weight calculations on the median rather than the geometric mean

because better correlation between costs and service mix would impact

the size of adjustments.

Although the payment simulations show potentially large percentage

losses and low payment-to-cost ratios for low-volume hospitals, we are

not proposing an adjustment for volume. The low-volume hospitals get a

much greater percent of their Medicare income from the provision of

outpatient services than the average, and total Medicare payments would

drop by 3.2 percent for rural low-volume hospitals and 1.7 percent for

urban low-volume hospitals. Low-volume hospitals have higher than

average standardized unit costs, which may be attributable to economies

of scale, undercoding, or cost allocations to the outpatient

departments that are not volume related. However, an adjustment to the

rates based on volume alone might reward inefficiency and create

adverse incentives such as a reduction in services in order to increase

payment rates.

We are particularly concerned about the potential impact of the

outpatient PPS on low-volume rural hospitals that are sole community

hospitals or Medicare-dependent hospitals.

39a. On page 47585, column two, first full paragraph, line six, the

sentence beginning ``Approximately 60 percent * * * is removed.

39b. On page 47585, the text in column three, first full paragraph,

through the third full paragraph is removed and replaced with the

following:

We also are not proposing adjustments for cancer or TEFRA hospitals

at this time. We believe that claims from cancer and TEFRA hospitals

have been undercoded, due to the lack of payment incentives for proper

coding of these services under the current system. Further analysis

will be conducted to determine if current coding practices explain the

negative impact. If we determine that cancer hospitals would be unduly

harmed because of the new outpatient PPS, we will consider whether an

adjustment or perhaps a transition period is needed to moderate the

impact. By statute, any adjustment would have to be budget neutral.

We do not believe that this action will restrict beneficiary access

because other hospitals provide many of the same services provided at

TEFRA hospitals. In addition, rehabilitation and long-term care

hospitals are less dependent than other hospitals on Medicare

outpatient revenues.

We are not proposing adjustments for any eye and ear hospitals

because payment simulations demonstrated an increase in payments under

the proposed PPS. We also are not proposing an adjustment for trauma

hospitals because these hospitals did not demonstrate significantly

higher costs and only lose a modest percentage of their total Medicare

payments, 0.8 percent, compared to all hospitals. We will assess the

need for additional adjustments and make any appropriate changes as

data become available under the new system.''

40. On pages 47583 through 47584, the table ``Changes for 1999

Outpatient Prospective Payment System'' is retitled ``Changes for

Outpatient Prospective Payment Systems'' and is corrected to read as

follows:

Changes for Outpatient Prospective Payment System

--------------------------------------------------------------------------------------------------------------------------------------------------------

No teaching adjustment Teaching adjustment

---------------------------------------------------------------------------------------

Percent Percent

change Percent change Percent

Number of Outpatient in Copay Standardized change in Copay Standardized change

hospitals percent Medicare Effect payment to is total Medicare Effect payment to in total

out- removed cost ratio Medicare out- removed cost ratio Medicare

patient payments patient payments

payments payments

(1) (2) (3) (4) (5) (6) (7) (8) (9) (10)

--------------------------------------------------------------------------------------------------------------------------------------------------------

ALL HOSPITALS............................ 5,335 9.9 -5.7 0.0 1.0000 -0.6 -5.7 0.0 1.0000 -0.6

NON-TEFRA HOSPITALS..................

4,818 10.0 -5.7 0.0 1.0001 -0.6 -5.7 0.0 1.0001 -0.6

NON-TEFRA HOSPITALS

GEOGRAPHIC LOCATION:

URBAN HOSPITALS...................... 2,643 9.3 -5.3 0.4 1.0053 -0.5 -5.2 0.5 1.0065 -0.5

LARGE URBAN AREAS................ 1,492 9.1 -6.6 -0.9 0.9890 -0.6 -6.3 -0.6 0.9928 -0.6

OTHER URBAN AREAS................ 1,151 9.6 -3.5 2.4 1.0287 -0.3 -3.7 2.1 1.0262 -0.4

RURAL HOSPITALS...................... 2,173 14.7 -7.4 -1.8 0.9784 -1.1 -7.9 -2.3 0.9734 -1.2

VOLUME (URBAN):

0-4,999 UNITS........................ 357 12.2 -13.6 -8.3 0.8493 -1.7 -13.9 -8.7 0.8458 -1.7

5,000-10, 999 UNITS.................. 502 9.6 -6.6 -0.9 0.9577 -0.6 -7.0 -1.3 0.9535 -0.7

11,000-20,999 UNITS.................. 597 9.0 -5.7 0.0 0.9839 -0.5 -6.1 -0.4 0.9802 -0.5

21,000-42,999 UNITS.................. 756 8.8 -4.2 1.6 1.0202 -0.4 -4.4 1.4 1.0180 -0.4

43,000 OR MORE UNITS................. 431 9.7 -5.7 0.0 1.0133 -0.6 -5.1 0.7 1.0201 -0.5

[[Page 35262]]

VOLUME (RURAL):

0-4,999 UNITS........................ 1,047 18.4 -17.4 -12.4 0.8216 -3.2 -17.8 -12.8 0.8170 -3.3

5,000-10,999 UNITS................... 601 15.3 -10.1 -4.6 0.9384 -1.5 -10.6 -5.2 0.9332 -1.6

11,000- 20,999 UNITS................. 333 13.7 -6.5 -0.8 0.9962 -0.9 -7.0 -1.4 0.9910 -1.0

21,000- 42,999 UNITS................. 170 13.5 -3.2 2.7 1.0435 -0.4 -3.7 2.2 1.0376 -0.5

43,000 OR MORE UNITS................. 22 13.3 -2.6 +3.3 1.0674 -0.3 -2.6 3.3 1.0677 -0.3

TEACHING STATUS:

NON-TEACHING......................... 3,814 11.2 -5.1 0.7 1.0029 -0.6 -5.6 0.1 0.9973 -0.6

FEWER THAN 100 RESIDENTS............. 758 9.1 -4.4 1.4 1.0256 -0.4 -4.9 0.9 1.0204 -0.4

100 OR MORE RESIDENTS................ 245 9.2 -10.6 -5.2 0.9414 -1.0 -7.9 -2.3 0.9697 -0.7

DISPROPORTIONATE SHARE PATIENT RATIO:

0.................................... 17 20.3 -20.0 -15.1 0.7376 -4.1 -20.0 -15.1 0.7377 -4.1

0.001-0.099.......................... 904 10.3 -6.6 -0.9 0.9860 -0.7 -6.9 -1.2 0.9825 -0.7

0.100-0.159.......................... 1,008 10.9 -3.7 2.2 1.0307 -0.4 -4.1 1.7 1.0261 -0.4

0.160-0.229.......................... 971 10.2 -4.8 1.0 1.0143 -0.5 -4.9 0.9 1.0132 -0.5

0.230-0.349.......................... 956 9.6 -6.2 -0.5 0.9977 -0.6 -6.0 -0.3 1.0001 -0.6

0.350 AND GREATER.................... 962 9.2 -8.4 -2.9 0.9579 -0.8 -7.5 -1.9 0.9675 -0.7

--------------------------------------------------------------------------------------------------------------------------------------------------------

Note: Urban and rural breakouts in this table are based on MSA status/location only.

41. On page 47596, in the table titled ``Estimated Annual Burden'',

column one, line two, ``419.42(b) and (d)'' is corrected to read

``419.42(b) and (c)''.

42. On page 47596, in the table titled ``Estimated Annual Burden'',

column one, line three, ``419.42(f)'' is corrected to read

``419.42(e)''.

42a. On page 47597, column one, first full paragraph, line 14,

``$300'' is corrected to read ``$600''.

42b. On page 47597, column two, the table is corrected to read as

follows:

------------------------------------------------------------------------

Impact ($

Fiscal year millions)

------------------------------------------------------------------------

1998.................................................... -940

1999.................................................... -1640

2000.................................................... -1320

2001.................................................... -1070

2002.................................................... -990

2003.................................................... -700

------------------------------------------------------------------------

42c. On page 47597, column two, line five of text, ``6.9'' is

corrected to read ``10.9''.

43. On pages 47597 through 47598, entire section F. is removed and

replaced with the following:

F. Quantitative Impact Analysis of the Proposed Policy Changes Under

the Prospective Payment System for Operating Costs and Capital Costs

Basis and Methodology of Estimates

The data used in developing quantitative analyses presented below

are taken from the CY 1996 cost and charge data and the most current

provider-specific file that is used for payment purposes. Our analysis

has several qualifications. First, we draw upon various sources for the

data used to categorize hospitals in the tables. In some cases, there

is a fair degree of variation in the data from different sources. We

have attempted to construct these variables with the best available

source overall. For individual hospitals, however, some

miscategorizations are possible.

Using CY 1996 cost and charge data, we simulated payments using the

current and proposed payment methodologies. We used both single and

multiple bills to calculate current and proposed Medicare and

beneficiary hospital outpatient payment amounts. Both current and

proposed payment estimates include operating and capital costs. We

excluded Kaiser, New York Health and Hospital Corporation, and all-

inclusive providers because reported charges on their cost reports are

not actual charges. Cost-to-charge ratios for these hospitals are not

comparable to all other hospitals. The exempted Maryland hospitals were

also excluded from the simulations; however, we included the 10 cancer

hospitals that will be paid under the proposed system.

We also trimmed outlier hospitals from the impact analysis because

we had indications that hospitals with extreme unit costs would not

allow us to access the impacts among the various classes of hospitals

accurately. First, we identified all the outlier hospitals by using an

edit of three standard deviations from the mean of the logged unit

costs. Trimming the data in this manner ensures that only the hospitals

with extremely high and low costs are eliminated from the impacts. In

doing this, we removed 96 hospitals of which 50 hospitals had extremely

low unit costs and 46 hospitals had extremely high unit costs. We

conducted a thorough analysis of these hospitals to ensure that we did

not remove any particular type of hospital (for example, teaching

hospitals) that would further harm the integrity of the data. We

speculate many of these hospitals are not coding accurately, and we

will continue to perform further analysis in this area after

implementation of the new APC system.

After removing the 54 exempted Maryland hospitals, the all-

inclusive rate hospitals, the outlier hospitals, and hospitals for

which we could not identify payment variables, we included 5,335

hospitals in our analysis. The impact analysis focuses on this set of

hospitals. The table below demonstrates the results of our analysis.

The table categorizes hospitals by various geographic and special

payment consideration groups to illustrate the varying impacts on

different types of hospitals. The first column represents the number of

hospitals in each category. The second column is the hospitals'

Medicate outpatient payments as a percentage of the hospitals' total

Medicare payment. The third column shows the percentage change in

Medicare outpatient payments comparing the current and proposed payment

systems. The fourth column shows the change in total Medicare

[[Page 35263]]

payments, resulting from implementing the PPS for outpatient services.

The top row of the table shows the overall impact on the 5,335

hospitals included in the analysis. We included as much of the data as

possible to the extent that we were able to capture all the provider

information necessary to determine payment. Further, our estimates

include the same set of services for both current and proposed APC

payments so that we could determine the impact as accurately as

possible. Since payment under the proposed APC system can only be

determined if bills are accurately coded, the data upon which the

impacts were developed do not reflect all CY 1996 hospital outpatient

services, but only those that were coded using valid HCPCS.

The second row identifies the hospitals in our analysis with the

exception of psychiatric, long-term care, children, and rehabilitation

hospitals, which account for 4,818 hospitals.

The next four rows of the table contain hospitals categorized

according to their geographic location (all urban, which is further

divided into large urban and other urban, or rural). There are 2,643

hospitals located in urban areas (MSAs or NECMAs) included in our

analysis. Among these, there are 1,492 hospitals located in large urban

areas (populations over 1 million), and 1,151 hospitals in other urban

areas (populations of 1 million or fewer). In addition, there are 2,173

hospitals in rural areas. The next two groupings are by bed-size

categories, shown separately for urban and rural hospitals. The next

category includes the volume of outpatient services, also shown

separately for urban and rural hospitals. The final groupings by

geographic location are by census divisions, also shown separately for

urban and rural hospitals.

The next three groupings examine the impacts of the proposed

changes on hospitals grouped by whether or not they have residency

programs (teaching hospitals that receive an indirect medical education

(IME) adjustment), receive disproportionate share hospital (DSH)

payments, or some combination of these two adjustments. There are 3,814

non-teaching hospitals in our analysis, 758 teaching hospitals with

fewer than 100 residents, and 245 teaching hospitals with 100 or more

residents.

In the DSH categories, hospitals are grouped according to their DSH

payment status. The next category groups hospitals considered urban

after geographic reclassification, in terms of whether they receive the

IME adjustment, the DSH adjustment, both, or neither. The next five

rows examine the impacts of the proposed changes on rural hospitals by

special payment groups (rural referral centers (RRCs), sole community

hospitals/essential access community hospitals (SCHs/EACHs), Medicare

dependent hospitals (MDHs), and SCHs and RRCs), as well as rural

hospitals not receiving a special payment designation. The RRCs (168),

SCH/EACHs (626), MDHs (365), and SCH and RRCs (55) shown here were not

reclassified for purposes of the standardized amount.

The next grouping is based on type of ownership. These data are

taken primarily from the FY 1995 Medicare cost report files, if

available (otherwise, FY 1994 data are used).

The next groupings are the specialty hospitals. The first set

includes the categorizations of eye and ear hospitals and trauma

hospitals (hospitals having a level one trauma center) and cancer

hospitals. The final groupings are the TEFRA hospitals, specifically

rehabilitation, psychiatric, long-term care, and children hospitals.

43a. On page 47598, the text in section G. Beginning in column two,

first full paragraph, through page 47599, column three, line 16, is

removed and replaced with the following:

G. Estimated Impact of the New APC System

Column 3 compares our estimate of payments, incorporating statutory

and policy changes reflected in this proposed rule for CY 1996, to our

estimate of payments in CY 1996 under the current payment system.

Percent differences between current and proposed payment reflect the

combined impact of a proportionally equal reduction in payments due to

the calculation of the conversion factor and distributional differences

attributable to variation in cost and charge structures among

hospitals. The methodology described in section 1833(t)(3)(C) of the

Act outlining the calculation of the conversion factor reduces payment

to hospitals overall by 5.7 percent relative to current law. As noted,

section 1833(t)(3)(C) of the Act requires us to set the conversion

factor so that total 1999 payments to hospitals under the proposed PPS

system equal Medicare payment amounts as calculated under the current

payment system plus beneficiary copayments as calculated under the

proposed system (20 percent of the APC median charge or, at minimum, 20

percent of the APC rate). The 5.7 percent loss implies that the

difference between the median and charges higher than the median was

proportionally larger than the difference between the median and

charges lower than the median. Because this reduction is incorporated

into the conversion factor, the 5.7 percent is distributed among

hospitals proportional to their total payments. After removing the

effect of the conversion factor calculation on total payments, the

remaining percent differences demonstrate the redistribution of

payments among hospitals and can be attributed to variation in both

costs and charge structures. Variation in costs among hospitals results

in differences between current and proposed Medicare payments, and

variation in charge structures results in differences between current

and proposed beneficiary copayment.

Redistributions may also occur as a result of current payment

methods. Total Medicare outpatient payments are less than reported

total costs because (in addition to the 5.8 and 10 percent reductions

for operating and capital costs) the blended payment methods applicable

to many surgical and diagnostic services often result in payments that

are less than reported costs. Other services such as medical visits,

chemotherapy services, and non-ASC approved surgeries are paid based on

hospital costs. The new system redistributes the current total Medicare

payments, based in part on cost-based payments and in part on blended

payment amounts, across all services. Hospitals, in the aggregate, will

receive proportionately less for services that are currently paid based

on costs and more for services that had been paid under blended payment

methods.

The impact on TEFRA hospitals is shown separately at the end of the

table; however, these hospitals were not included in determining the

impact on any of the other categories (for example, geographic

location, bed size, volume, etc.). These hospitals demonstrated a very

low service mix, but an average unit cost that approximates the

national average. We believe that billing practices may account for

this phenomenon. Some TEFRA hospitals appear to undercode HCPCS and

units. This may be because correct coding is not required for payment

or because they bill an all-inclusive rate. Undercoding or billing an

all-inclusive rate could account for their low-volume, low-service mix,

and average cost per unit. We expect that once these hospitals begin to

code HCPCS according to the new payment system, new payments will

better reflect current payments.

In general, differences among hospital classifications for short-

term acute care

[[Page 35264]]

hospitals were relatively small. This is, payments under the proposed

outpatient system were within a few percentage points of payments made

under current law. The following discussion highlights some of the

variation in payments among hospital classifications.

Based on comparing current and proposed payment estimates, minor

teaching hospitals lose 4.4 percent, while major teaching hospitals

experience a reduction of 10.6 percent. Non-teaching hospitals

experience a decrease of 5.1 percent. However, major teaching hospitals

gain less of their total Medicare income (9.2 percent) from outpatient

services than the national average (10 percent). This results in a 1

percent loss in their total Medicare income.

Hospitals with a high percentage of low-income patients

(disproportionate share patient percentage greater than or equal to

0.35) appear to experience payment reductions of 8.4 percent relative

to current law. These hospitals have lower than average volume, and

like major teaching hospitals, they receive a smaller than average

percent of their Medicare income from outpatient services.

Rural hospitals would lose about 7.4 percent, large urban hospitals

would lose about 6.6 percent, and other urban hospitals would lose 3.5

under the new system. Rural hospitals get a greater percentage of their

Medicare income (14.7 percent) from outpatient services compared to the

national average of 10 percent.

Low-volume hospitals appear to lose a large percentage of their

payments under the new payment system (17.4 percent for rural and 13.6

percent for urban hospitals with less than 5,000 units of service). We

believe several factors are contributing to this outcome, including

undercoding, lack of economies of scale, and underpayment due to the

reliance on the median instead of the geometric mean in the calculation

of APC weights. The majority of these hospitals (about 75 percent) are

rural. For these small hospitals, some of the higher standardized unit

costs could be attributed to economies of scale. These low-volume rural

hospitals also receive a greater percentage of their Medicare income

(18.4 percent) from outpatient services than the average.

43b. On page 47599, the table titled: Estimated Impact of a

Transition Policy on Medicare Outpatient Payment for Medicare-Dependent

and Sole Community Hospitals,'' is corrected to read as follows:

Estimated Impact of a Transition Policy on Medicare Outpatient Payments

for Medicare-Dependent and Sole Community Hospitals

[In percent]

------------------------------------------------------------------------

Year 1 Year 2 Year 3 Year 4

------------------------------------------------------------------------

MDH......................... -2.8 -5.6 -8.5 -11.3

SCH......................... -3.2 -6.4 -9.7 -12.9

SCH/RRC..................... -1.9 -3.8 -5.8 -7.7

------------------------------------------------------------------------

43c. On page 47599, the text in section G. beginning in column two,

line seven from the bottom through page 47600, is corrected to read as

follows:

As noted above, rural hospitals lose a larger percent of their

payments than urban hospitals. Among the census divisions, rural New

England hospitals experience the largest negative payment impact of

12.2 percent. This could be attributed to higher nonlabor costs in New

England.

Urban census division breakouts reveal that Middle Atlantic urban

hospitals have the largest negative payment impact of 9.7 percent.

Hospitals located in Puerto Rico gain because of the change in the

beneficiary copayment. Previously these hospitals received 20 percent

of their charges from the beneficiary, whereas under the new PPS they

would receive 20 percent of the APC median charge or, at minimum, they

would receive 20 percent of the payment rate. Hospitals in Puerto Rico

gain under the new proposed system because 20 percent of their charges

are lower than 20 percent of the APC median charges or 20 percent of

the rates

Among special categories of rural hospitals, MDHs and SCHs/EACHs

would experience decreases of 11.3 and 12.9 percent, respectively, Some

of this decrease may be attributed to the impact on low-volume rural

hospitals.

Cancer hospitals experience a 32.4 percent loss. Several factors

may contribute to this loss. Undercoding could be a factor contributing

to the percentage loss. In addition, the current requirements for batch

billing of services such as chemotherapy and radiation therapy and the

fact that we used only single procedure bills to calculate group

weights may also have contributed to the impact on these hospitals.

Further analysis will be conducted to determine if current coding

practices explain the negative impact. We will be verifying the

accuracy of the rates for these types of procedures. Specifically, the

APC weights were calculated using single bill procedures. Using single

bill procedures to compute a weight for services that are not typically

billed as a single procedure could result in rates that are not

accurate for these services. We will verify the accuracy of the rates

for these types of procedures by analyzing the costs from the multiple

bills. If further analysis reveals that cancer hospitals would be

unduly harmed because of the new outpatient PPS, we will consider

whether an adjustment or perhaps a transition period is needed to

moderate the impact. By statute, any adjustment would have to be budget

neutral. Until further analysis can be conducted, we are not proposing

an adjustment for cancer hospitals.

In accordance with the provisions of Executive Order 12866, this

regulation was reviewed by the Office of Management and Budget.

44. On pages 47601 through 47604, the table titled ``Changes for

Outpatient Prospective Payment System'' is re-titled ``Impact of

Outpatient Prospective Payment System'' and corrected to read as

follows:

[[Page 35265]]

Impact of Outpatient Prospective Payment System

----------------------------------------------------------------------------------------------------------------

Percent Percent

change in change in

Number of Outpatient Medicare total

hospitals percent outpatient Medicare

payments payments

(1) (2) (3) (4)

----------------------------------------------------------------------------------------------------------------

ALL HOSPITALS............................................... 5,335 9.9 -5.7 -0.6

NON-TEFRA HOSPITALS.....................................

4,819 10.0 -5.7 -0.6

NON-TEFRA HOSPITALS

GEOGRAPHIC LOCATION:

URBAN HOSPITALS......................................... 2,643 9.3 -5.3 -0.5

LARGE URBAN AREAS................................... 1,492 9.1 -6.6 -0.6

OTHER URBAN AREAS................................... 1,151 9.6 -3.5 -0.3

RURAL HOSPITALS......................................... 2,173 14.7 -7.4 -1.1

BED SIZE (URBAN):

0-99 BEDS............................................... 646 15.4 -7.3 -1.1

100-199 BEDS............................................ 910 10.4 -4.2 -0.4

200-299 BEDS............................................ 531 9.2 -3.8 -0.3

300-499 BEDS............................................ 418 8.6 -4.8 -0.4

500 OR MORE BEDS........................................ 138 8.3 -9.7 -0.8

BED SIZE (RURAL):

0-49 BEDS............................................... 1,138 19.6 -13.8 -2.7

50-99 BEDS.............................................. 641 15.5 -8.4 -1.3

100-149 BEDS............................................ 229 13.5 -6.0 -0.8

150-199 BEDS............................................ 91 13.0 -4.3 -0.6

200 OR MORE BEDS........................................ 74 11.4 -2.9 -0.3

VOLUME (URBAN):

0-4,999 UNITS........................................... 357 12.2 -13.6 -1.7

5,000-10,999 UNITS...................................... 502 9.6 -6.6 -0.6

11,000-20,999 UNITS..................................... 597 9.0 -5.7 -0.5

21,000-42,999 UNITS..................................... 756 8.8 -4.2 -0.4

43,000 OR MORE UNITS.................................... 431 9.7 -5.7 -0.6

VOLUME (RURAL):

0-4,999 UNITS........................................... 1,047 18.4 -17.4 -3.2

5,000-10,999 UNITS...................................... 601 15.3 -10.1 -1.5

11,000-20,999 UNITS..................................... 333 13.7 -6.5 -0.9

21,000-42,999 UNITS..................................... 170 13.5 -3.2 -0.4

43,000 OR MORE UNITS.................................... 22 13.3 -2.6 -0.3

URBAN BY CENSUS DIV.:

NEW ENGLAND............................................. 148 10.8 -3.2 -0.3

MIDDLE ATLANTIC......................................... 391 8.3 -9.7 -0.8

SOUTH ATLANTIC.......................................... 393 8.6 -5.8 -0.5

EAST NORTH CENTRAL...................................... 446 10.6 -4.3 -0.5

EAST SOUTH CENTRAL...................................... 158 7.9 -1.8 -0.1

WEST NORTH CENTRAL...................................... 187 9.5 -6.5 -0.6

WEST SOUTH CENTRAL...................................... 337 9.7 -7.4 -0.7

MOUNTAIN................................................ 120 10.3 -2.2 -0.2

PACIFIC................................................. 428 9.3 -1.8 -0.2

PUERTO RICO............................................. 35 6.6 8.5 0.6

RURAL BY CENSUS DIV.:

NEW ENGLAND............................................. 56 16.9 -12.2 -2.1

MIDDLE ATLANTIC......................................... 81 13.5 0.2 0.0

SOUTH ATLANTIC.......................................... 282 11.8 -7.7 -0.9

EAST NORTH CENTRAL...................................... 287 15.8 -6.1 -1.0

EAST SOUTH CENTRAL...................................... 266 11.2 -6.5 -0.7

WEST NORTH CENTRAL...................................... 516 19.6 -10.9 -2.1

WEST SOUTH CENTRAL...................................... 339 14.2 -10.6 -1.5

MOUNTAIN................................................ 207 16.7 -8.3 -1.4

PACIFIC................................................. 137 16.4 -3.4 -0.6

PUERTO RICO............................................. 2 6.6 28.5 1.9

TEACHING STATUS:

NON-TEACHING............................................ 3,814 11.2 -5.1 -0.6

FEWER THAN 100 RESIDENTS................................ 758 9.1 -4.4 -0.4

100 OR MORE RESIDENTS................................... 245 9.2 -10.6 -1.0

DISPROPORTIONATE SHARE PATIENT RATIO:

0....................................................... 17 20.3 -20.0 -4.1

0.001-0.099............................................. 904 10.3 -6.6 -0.7

0.100-0.159............................................. 1,008 10.9 -3.7 -0.4

0.160-0.229............................................. 971 10.2 -4.8 -0.5

0.230-0.349............................................. 956 9.6 -6.2 -0.6

0.350 AND GREATER....................................... 962 9.2 -8.4 -0.8

[[Page 35266]]

URBAN TEACHING AND DSH:

BOTH TEACHING AND DSH................................... 944 9.0 -6.6 -0.6

TEACHING AND NO DSH..................................... 2 19.8 -31.0 -6.1

NO TEACHING AND DSH..................................... 1,688 9.8 -3.7 -0.4

NO TEACHING AND NO DSH.................................. 9 30.4 7.2 2.2

RURAL HOSPITAL TYPES:

NONSPECIAL STATUS HOSPITALS............................. 944 15.0 -6.8 -1.0

RRC..................................................... 168 12.4 -2.3 -0.3

SCH/EACH................................................ 626 16.4 -12.9 -2.1

MDH..................................................... 365 18.2 -11.3 -2.1

SCHM/EACH AND RRC....................................... 55 13.7 -7.7 -1.1

TYPE OF OWNERSHIP:

VOLUNTARY............................................... 2,839 9.9 -5.6 -0.6

PROPRIETARY............................................. 671 7.9 -4.7 -0.4

GOVERNMENT.............................................. 1,308 12.3 -7.4 -0.9

SPECIALTY HOSPITALS:

EYE AND EAR............................................. 10 31.1 10.4 3.2

TRAUMA.................................................. 157 9.1 -8.4 -0.8

CANCER.................................................. 10 22.0 -32.4 -7.1

TEFRA HOSPITALS:

REHABILITATION.......................................... 138 3.7 -11.1 -0.4

PSYCHIATRIC............................................. 278 10.7 -0.5 -0.1

LONG-TERM CARE.......................................... 63 3.7 -19.6 -0.7

CHILDREN'S.............................................. 38 9.4 -23.9 -2.2

----------------------------------------------------------------------------------------------------------------

Note: Urban and rural breakouts in this table are based on MSA status/location only.

Correction to the Regulations Text

Sec. 419.32 [Corrected]

45. On page 47613, in the regulations text, in column one, in

paragraph (b)(1), in the second line, ``paragraph (c)(2)'' is corrected

to read ``paragraph (b)(2)''; and in paragraph (b)(2), in the fourth

line, ``paragraph (c)(1)'' is corrected to read ``paragraph (b)(1)''.

Corrections to the Addenda

46. On pages 47615 through 47620, Addendum A is corrected to read

as follows:

Addendum A.--List of Proposed Hospital Outpatient Ambulatory Payment Classes with Status Indicators, Relative

Weights, Payment Rates, and Coinsurance Amounts

----------------------------------------------------------------------------------------------------------------

\7\ Minimum

APC Group title Status Relative Payment National unadjusted

indicator weight rate unadjusted coinsurance

----------------------------------------------------------------------------------------coinsurance-------------

\6\ 020 Partial ................... P 4.02 $206.71 $46.78 $41.34

Hospitalizaiton.

031 Dental procedures.. ................... S 1.37 $70.45 $14.09 $14.09

061 Level I ................... X 1.15 $59.13 $37.52 $11.83

Chemotherapeutic

agents.

062 Level II ................... X 1.78 $91.53 $36.61 $18.31

Chemotherapeutic

agents.

063 Level III ................... X 2.94 $151.17 $110.97 $30.24

Chemotherapeutic

agents.

064 Level IV ................... X 4.15 $213.39 $138.99 $42.68

Chemotherapeutic

agents.

089 Neuropsychological ................... X 4.06 $208.77 $46.10 $41.75

Testing.

090 Monitoring ................... X 0.85 $43.71 $12.20 $8.74

psychiatric drugs.

\1\ 091 Brief Individual ................... S 1.09 $56.05 $14.01 $11.21

Psychotherapy.

\2\ 092 Extended Individual ................... S 1.63 $83.81 $21.47 $16.76

Psychotherapy.

093 Family ................... S 1.56 $80.22 $20.11 $16.04

Psychotherapy.

094 Group Psychotherapy ................... S 1.31 $67.36 $19.89 $13.47

121 Level I needle ................... T 0.63 $32.39 $21.02 $6.48

biopsy/aspiration.

122 Level II needle ................... T 4.59 $236.02 $113.00 $47.20

biopsy/aspiration.

131 Level I incision & ................... T 1.93 $99.24 $36.61 $19.85

drainage.

132 Level II incision & ................... T 5.63 $289.49 $132.89 $57.90

drainage.

137 Nail procedures.... ................... T 0.60 $30.85 $9.27 $6.17

141 Level I Destruction ................... T 0.52 $26.74 $9.49 $5.35

of lesion.

142 Level II ................... T 2.94 $151.17 $54.24 $30.24

Destruction of

lesion.

151 Level I debridement/ ................... T 1.63 $83.81 $33.22 $16.76

destruction.

152 Level II ................... T 10.07 $517.80 $251.54 $103.56

debridement/

destruction.

161 Level I excision/ ................... T 3.43 $176.37 $75.71 $35.27

biopsy.

162 Level II excision/ ................... T 5.59 $287.44 $125.66 $57.49

biopsy.

163 Level III excision/ ................... T 10.48 $538.88 $260.80 $107.78

biopsy.

181 Level I skin repair ................... T 2.17 $111.58 $44.07 $22.32

182 Level II skin ................... T 4.11 $211.34 $92.43 $42.27

repair.

183 Level III skin ................... T 11.04 $567.68 $283.18 $113.54

repair.

[[Page 35267]]

184 Level IV skin ................... T 14.85 $763.59 $397.99 $152.72

repair.

197 Incision/excision ................... T 11.94 $613.95 $308.26 $122.79

breast.

198 Breast ................... T 18.63 $957.95 $523.42 $191.59

reconstruction/

mastectomy.

200 Arthrocentesis & ................... T 1.76 $90.50 $39.10 $18.10

Ligament/Tendon

Injection.

207 Closed treatment ................... T 1.70 $87.41 $32.32 $17.48

fracture finger/

toe/trunk.

209 Closed treatment ................... T 1.94 $99.75 $37.74 $19.95

fracture/

dislocation/except

finger/toe/trunk.

210 Bone/joint ................... T 10.06 $517.29 $279.34 $103.46

manipulation under

anesthesia.

216 Open/percutaneous ................... T 20.09 $1,033.03 $524.09 $206.61

treatment fracture

or dislocation.

217 Arthroplasty....... ................... T 20.54 $1,056.17 $530.42 $211.23

218 Arthroplasty with ................... T 27.80 $1,429.48 $720.71 $285.90

prosthesis.

226 Maxillofacial ................... T 1.56 $80.22 $21.92 $16.04

prostheses.

231 Level I skull and ................... T 11.31 $581.56 $286.79 $116.31

facial bone

procedures.

232 Level II skull and ................... T 23.82 $1,224.82 $636.87 $244.96

facial bone

procedures.

251 Level I ................... T 13.88 $713.71 $365.89 $142.74

musculoskeletal

procedures.

252 Level II ................... T 19.24 $989.32 $512.34 $197.86

Musculoskeletal

Procedures.

253 Level III ................... T 25.74 $1,323.55 $684.55 $264.71

Musculoskeletal

Procedures.

254 Level IV ................... T 32.70 $1,681.43 $922.98 $336.29

Musculoskeletal

Procedures.

261 Level I Hand ................... T 10.41 $535.28 $259.00 $107.06

Musculoskeletal

Procedures.

262 Level II Hand ................... T 18.07 $929.16 $475.96 $185.83

Musculoskeletal

Procedures.

271 Level I Foot ................... T 14.12 $726.05 $365.44 $145.21

Musculoskeletal

Procedures.

272 Level II Foot ................... T 16.11 $828.38 $411.09 $165.68

Musculoskeletal

Procedures.

276 Bunion Procedures.. ................... T 19.00 $976.98 $495.39 $195.40

280 Diagnostic ................... T 22.15 $1,138.95 $581.72 $227.79

Arthroscopy.

281 Level I Surgical ................... T 22.37 $1,150.27 $589.18 $230.05

Arthroscopy.

282 Level II Surgical ................... T 23.65 $1,216.08 $609.97 $243.22

Arthroscopy.

286 Arthroscopically- ................... T 27.69 $1,423.82 $791.90 $284.76

Aided Procedures.

311 Level I ENT ................... T 1.41 $72.50 $20.57 $14.50

Procedures.

312 Level II ENT ................... T 7.07 $363.54 $170.86 $72.71

Procedures.

313 Level III ENT ................... T 15.46 $794.95 $407.70 $158.99

Procedures.

314 Level IV ENT ................... T 25.15 $1,293.21 $687.72 $258.64

Procedures.

\5\ 317 Implantation of ................... T ......... ......... ........... ...........

Cochlear Device.

318 Nasal Cauterization/ ................... T 2.07 $106.44 $38.87 $21.29

Packing.

319 Tonsil/Adenoid ................... T 16.20 $833.00 $463.53 $166.60

Procedures.

320 Thoracentesis/ ................... T 3.09 $158.89 $80.91 $31.78

Lavage Procedures.

331 Level I Endoscopy ................... T 0.57 $29.31 $14.01 $5.86

Upper Airway.

332 Level II Endoscopy ................... T 9.67 $497.23 $242.72 $99.45

Upper Airway.

333 Level III Endoscopy ................... T 16.81 $864.37 $461.04 $172.87

Upper Airway.

336 Endoscopy Lower ................... T 7.24 $372.28 $195.49 $74.46

Airway.

339 Injection of ................... T 0.98 $50.39 $19.66 $10.08

Sclerosing

Solution.

341 Level I Needle and ................... T 0.09 $4.63 $2.49 $0.93

Catheter Placement.

342 Level II Needle and ................... T 2.61 $134.21 $68.70 $26.84

Catheter Placement.

343 Level III Needle ................... T 8.76 $450.44 $240.24 $90.09

and Catheter

Placement.

346 Placement ................... T 4.63 $238.07 $121.59 $47.61

Transvenous Caths/

Cutdown.

347 Injection ................... T 2.57 $132.15 $62.38 $26.43

Procedures for

Interventional

Radiology.

360 Removal/Revision, ................... T 6.04 $310.58 $138.54 $62.12

Pacemaker/Vascular

Device.

367 Vascular Ligation.. ................... T 17.02 $875.17 $441.15 $175.03

368 Vascular Repair/ ................... T 22.59 $1,161.58 $647.49 $232.32

Fistula

Construction.

369 Blood and Blood ................... T 6.33 $325.49 $155.49 $65.10

Product Exchange.

396 Lymph Node ................... T 12.98 $667.43 $334.48 $133.49

Excisions.

397 Thyroid/ ................... T 19.12 $983.15 $542.17 $196.63

Lymphadenectomy

Procedures.

406 Esophageal Dilation ................... T 4.17 $214.42 $106.67 $42.88

without Endoscopy.

407 Esophagoscopy...... ................... T 6.89 $354.28 $189.39 $70.86

417 Diagnostic Upper GI ................... T 6.35 $326.52 $179.22 $65.30

Endoscopy.

418 Therapeutic Upper ................... T 7.44 $382.56 $213.57 $76.51

GI Endoscopy.

419 Small Intestine ................... T 6.83 $351.20 $164.08 $70.24

Endoscopy.

426 Diagnostic Lower GI ................... T 6.74 $346.57 $185.32 $69.31

Endoscopy.

427 Therapeutic Lower ................... T 8.09 $415.99 $222.84 $83.20

GI Endoscopy.

437 Therapeutic ................... T 6.54 $336.29 $173.79 $67.26

Anoscopy.

446 Diagnostic ................... T 2.54 $130.61 $64.86 $26.12

Sigmoidoscopy.

447 Therapeutic ................... T 7.06 $363.03 $191.87 $72.61

Proctosigmoidoscop

y.

448 Therapeutic ................... T 5.28 $271.50 $139.22 $54.30

Flexible

Sigmoidoscopy.

449 Complex GI ................... T 7.63 $392.33 $213.57 $78.47

Endoscopy.

451 Level I Anal/Rectal ................... T 2.42 $124.44 $53.56 $24.89

Procedures.

452 Level II Anal/ ................... T 4.52 $232.42 $103.06 $46.48

Rectal Procedures.

453 Level III Anal/ ................... T 16.26 $836.09 $440.47 $167.22

Rectal Procedures.

456 Endoscopic ................... T 9.61 $494.15 $249.05 $98.83

Retrograde

Cholangio-

Pancreatography

(ERCP).

458 Percutaneous ................... T 6.81 $350.17 $181.70 $70.03

Biliary Endoscopic

Procedures.

459 Peritoneal and ................... T 17.85 $917.85 $497.88 $183.57

Abdominal

Procedures.

466 Hernia/Hydrocele ................... T 20.67 $1,062.85 $556.64 $212.57

Procedures.

470 Tube Procedures.... ................... T 2.19 $112.61 $54.92 $22.52

521 Level I ................... T 4.89 $251.44 $110.06 $50.29

Cystourethroscopy

and other

Genitourinary

Procedures.

[[Page 35268]]

522 Level II ................... T 10.15 $521.91 $259.45 $104.38

Cystourethroscopy

and other

Genitourinary

Procedures.

523 Level III ................... T 16.35 $840.72 $438.89 $168.14

Cystourethroscopy

and other

Genitourinary

Procedures.

524 Level IV ................... T 27.20 $1,398.62 $824.90 $279.72

Cystourethroscopy

and other

Genitourinary

Procedures.

527 Lithotripsy........ ................... T 43.48 $2,235.74 $1,372.95 $447.15

529 Simple Urinary ................... T 2.33 $119.81 $59.66 $23.96

Studies and

Procedures.

530 Genitourinary ................... T 2.46 $126.49 $53.34 $25.30

Procedures.

531 Level I Urethral ................... T 18.59 $955.90 $531.55 $191.18

Procedures.

532 Level II Urethral ................... T 23.02 $1,183.69 $588.50 $236.74

Procedures.

536 Circumcision....... ................... T 12.89 $662.80 $321.60 $132.56

537 Penile Procedures.. ................... T 28.65 $1,473.18 $872.36 $294.64

538 Insertion of Penile ................... T 48.41 $2,489.24 $1,563.47 $497.85

Prosthesis.

546 Testes/Epididymis ................... T 16.54 $850.49 $449.51 $170.10

Procedures.

547 Prostate Biopsy.... ................... T 4.39 $225.73 $125.20 $45.15

550 Surgical ................... T 16.46 $846.37 $445.22 $169.27

Hysteroscopy.

551 Level I Laparoscopy ................... T 24.61 $1,265.45 $701.73 $253.09

552 Level II ................... T 37.09 $1,907.17 $1,053.84 $381.43

Laparoscopy.

561 Level I Female ................... T 1.46 $75.07 $24.41 $15.01

Reproductive

Procedures.

562 Level II Female ................... T 12.30 $632.47 $325.44 $126.49

Reproductive

Procedures.

563 Level III Female ................... T 16.50 $848.43 $461.72 $169.69

Reproductive

Procedures.

567 D & C.............. ................... T 13.18 $677.72 $360.70 $135.54

568 Infertility ................... T 2.79 $143.46 $55.60 $28.69

Procedures.

578 Pregnancy and ................... T 1.17 $60.16 $32.77 $12.03

Neonatal Care

Procedures.

580 Vaginal Delivery... ................... T 4.31 $221.62 $44.32 $44.32

586 Therapeutic ................... T 11.98 $616.01 $409.29 $123.20

Abortion.

587 Spontaneous ................... T 12.96 $666.40 $347.14 $133.28

Abortion.

600 Spinal Tap......... ................... T 2.41 $123.92 $61.47 $24.78

601 Level I Nervous ................... T 3.00 $154.26 $74.13 $30.85

System Injections.

602 Level II Nervous ................... T 3.19 $164.03 $87.01 $32.81

System Injections.

616 Implantation of ................... T 11.85 $609.33 $329.06 $121.87

Neurostimulator

Electrodes.

617 Revision/Removal ................... T 11.31 $581.56 $280.01 $116.31

Neurological

Device.

618 Implantation of ................... T 24.78 $1,274.19 $808.18 $254.84

Neurological

Device.

631 Level I Nerve ................... T 12.70 $653.03 $329.06 $130.61

Procedures.

632 Level II Nerve ................... T 16.48 $847.40 $453.58 $169.48

Procedures.

648 Laser Retinal ................... T 3.76 $193.34 $93.56 $38.67

Procedures.

649 Laser Eye ................... T 4.37 $224.71 $111.64 $44.94

Procedures except

Retinal.

651 Level I Anterior ................... T 6.85 $352.23 $171.99 $70.45

Segment Eye

Procedures.

652 Level II Anterior ................... T 16.35 $840.72 $433.92 $168.14

Segment Eye

Procedures.

667 Cataract Procedures ................... T 20.35 $1,046.40 $538.11 $209.28

668 Cataract Procedures ................... T 22.02 $1,132.27 $617.21 $226.45

with IOL Insert.

670 Corneal Transplant. ................... T 30.78 $1,582.71 $885.92 $316.54

676 Posterior Segment ................... T 5.87 $301.84 $138.54 $60.37

Eye Procedures.

677 Strabismus/Muscle ................... T 16.11 $828.38 $428.95 $165.68

Procedures.

681 Level I Eye ................... T 1.65 $84.84 $30.51 $16.97

Procedures.

682 Level II Eye ................... T 3.41 $175.34 $80.68 $35.07

Procedures.

683 Level III Eye ................... T 9.56 $491.58 $252.44 $98.32

Procedures.

684 Level IV Eye ................... T 13.26 $681.83 $341.94 $136.37

Procedures.

690 Vitrectomy......... ................... T 30.39 $1,562.65 $845.69 $312.53

700 Plain Film......... ................... X 0.80 $41.14 $22.37 $8.23

706 Miscellaneous ................... X 1.43 $73.53 $39.10 $14.71

Radiological

Procedures.

710 Computerized Axial ................... S 4.98 $256.07 $173.12 $51.21

Tomography.

716 Fluoroscopy........ ................... X 1.39 $71.47 $40.00 $14.29

720 Magnetic Resonance ................... S 6.37 $327.55 $204.98 $65.51

Angiography.

726 Magnetic Resonance ................... S 7.91 $406.73 $256.06 $81.35

Imaging.

728 Myelography........ ................... S 3.50 $179.97 $91.98 $35.99

730 Arthography........ ................... S 2.30 $118.27 $65.77 $23.65

736 Digestive Radiology ................... S 1.85 $95.13 $53.79 $19.03

737 Diagnostic ................... S 2.69 $138.32 $81.81 $27.66

Urography.

738 Therapeutic ................... S 3.74 $192.31 $104.86 $38.46

Radiologic

Procedures.

739 Diagnostic ................... S 5.33 $274.07 $150.74 $54.81

Angiography and

Venography.

746 Mammography........ ................... S 0.69 $35.48 $19.44 $7.10

747 Diagnostic ................... S 1.65 $84.84 $54.47 $16.97

Ultrasound Except

Vascular.

749 Guidance under ................... X 2.22 $114.15 $70.06 $22.83

Ultrasound.

750 Therapeutic ................... X 0.96 $49.36 $25.99 $9.87

Radiation

Treatment Planning.

751 Level I Therapeutic ................... X 1.15 $59.13 $33.22 $11.83

Radiation

Treatment

Preparation.

752 Level II ................... X 3.48 $178.94 $86.56 $35.79

Therapeutic

Radiation

Treatment

Preparation.

757 Radiation Therapy.. ................... S 2.26 $116.21 $52.43 $23.24

758 Hyperthermic ................... S 5.08 $261.21 $137.18 $52.24

Therapies.

759 Brachytherapy and ................... S 7.98 $410.33 $157.97 $82.07

Complex

Radioelement

Applications.

760 PET Scans.......... ................... S 14.89 $765.64 $419.46 $153.13

761 Standard Non- ................... S 1.80 $92.56 $54.01 $18.51

Imaging Nuclear

Medicine.

762 Complex Non-Imaging ................... S 2.02 $103.87 $55.82 $20.77

Nuclear Medicine.

771 Standard Planar ................... S 3.81 $195.91 $117.29 $39.18

Nuclear Medicine.

[[Page 35269]]

772 Complex Planar ................... S 4.26 $219.05 $128.37 $43.81

Nuclear Medicine.

781 Standard SPECT ................... S 5.43 $279.21 $155.04 $55.84

Nuclear Medicine.

782 Complex SPECT ................... S 9.00 $462.78 $267.13 $92.56

Nuclear Medicine.

791 Standard ................... S 14.74 $757.93 $539.91 $151.59

Therapeutic

Nuclear Medicine.

792 Complex Therapeutic ................... S 4.81 $247.33 $143.06 $49.47

Nuclear Medicine.

861 Immunology Tests... ................... X 0.13 $6.68 $3.62 $1.34

881 Level I Pathology.. ................... X 0.22 $11.31 $6.78 $2.26

882 Level II Pathology. ................... X 0.39 $20.05 $11.75 $4.01

883 Level III Pathology ................... X 0.69 $35.48 $20.34 $7.10

900 Critical Care...... ................... S 7.54 $387.71 $145.09 $77.54

901 Level I ................... X 0.07 $3.60 $2.49 $0.72

Immunization.

902 Level II ................... X 1.31 $67.36 $38.19 $13.47

Immunization.

903 Level III ................... X 1.00 $51.42 $24.86 $10.28

Immunization.

906 Infusion Therapy ................... X 1.93 $99.24 $57.18 $19.85

except

Chemotherapy.

907 Intramuscular ................... X 0.74 $38.05 $11.53 $7.61

Injections.

\3\ 911 Low Level Clinic Well care and V 1.24 $63.76 $15.14 $12.75

11 Visits. administrative.

91118 Low Level Clinic Skin and breast V 0.83 $42.68 $9.27 $8.54

Visits. diseases.

91124 Low Level Clinic Musculoskeletal V 0.87 $44.74 $9.49 $8.95

Visits. diseases.

91131 Low Level Clinic Ear, nose, mouth V 0.81 $41.65 $9.04 $8.33

Visits. and throat

diseases.

91133 Low Level Clinic Respiratory system V 0.83 $42.68 $8.59 $8.54

Visits. diseases.

91136 Low Level Clinic Cardiovascular V 0.87 $44.74 $8.95 $8.95

Visits. system diseases.

91141 Low Level Clinic Digestive system V 0.96 $49.36 $10.40 $9.87

Visits. diseases.

91153 Low Level Clinic Kidney, urinary V 0.91 $46.79 $9.49 $9.36

Visits. tract and male

genital diseases.

91156 Low Level Clinic Female genital V 0.93 $47.82 $9.56 $9.56

Visits. system diseases.

91157 Low Level Clinic Pregnancy and V 1.37 $70.45 $17.85 $14.09

Visits. neonatal care.

91163 Low Level Clinic Nervous system V 0.98 $50.39 $10.17 $10.08

Visits. diseases.

91168 Low Level Clinic Eye diseases....... V 0.96 $49.36 $10.40 $9.87

Visits.

91172 Low Level Clinic Trauma and V 1.06 $54.51 $14.24 $10.90

Visits. poisoning.

91178 Low Level Clinic Major signs, V 1.52 $78.16 $21.47 $15.63

Visits. symptoms and

findings.

91182 Low Level Clinic Endocrine, V 0.87 $44.74 $9.04 $8.95

Visits. nutritional and

metabolic diseases.

91186 Low Level Clinic Immunologic and V 1.07 $55.02 $11.53 $11.00

Visits. hematologic

diseases.

91188 Low Level Clinic Malignancy......... V 0.72 $37.02 $8.14 $7.40

Visits.

\1\ 911 Low Level Clinic Psychiatric V 1.09 $56.05 $14.01 $11.21

91 Visits. disorders.

91197 Low Level Clinic Infectious disease. V 1.02 $52.45 $11.53 $10.49

Visits.

\4\ 911 Low Level Clinic Unknown cause of V 1.41 $72.50 $24.86 $14.50

99 Visits. mortality.

\3\ 913 Mid Level Clinic Well care and V 1.24 $63.76 $15.14 $12.75

11 Visits. administrative.

91318 Mid Level Clinic Skin and breast V 0.98 $50.39 $10.08 $10.08

Visits. diseases.

91324 Mid Level Clinic Musculoskeletal V 0.96 $49.36 $9.87 $9.87

Visits. diseases.

91331 Mid Level Clinic Ear, nose, mouth V 0.94 $48.33 $9.67 $9.67

Visits. and throat

diseases.

91333 Mid Level Clinic Respiratory system V 0.93 $47.82 $9.56 $9.56

Visits. diseases.

91336 Mid Level Clinic Cardiovascular V 1.00 $51.42 $10.28 $10.28

Visits. system diseases.

91341 Mid Level Clinic Digestive system V 1.00 $51.42 $10.28 $10.28

Visits. diseases.

91353 Mid Level Clinic Kidney, urinary V 1.00 $51.42 $10.28 $10.28

Visits. tract and male

genital diseases.

91356 Mid Level Clinic Female genital V 1.04 $53.48 $10.70 $10.70

Visits. system diseases.

91357 Mid Level Clinic Pregnancy and V 1.33 $68.39 $13.68 $13.68

Visits. neonatal care.

91363 Mid Level Clinic Nervous system V 1.04 $53.48 $10.70 $10.70

Visits. diseases.

91368 Mid Level Clinic Eye diseases....... V 0.85 $43.71 $8.74 $8.74

Visits.

91372 Mid Level Clinic Trauma and V 1.06 $54.51 $10.90 $10.90

Visits. poisoning.

91378 Mid Level Clinic Major signs, V 1.13 $58.10 $11.62 $11.62

Visits. symptoms and

findings.

91382 Mid Level Clinic Endocrine, V 1.00 $51.42 $10.28 $10.28

Visits. nutritional and

metabolic diseases.

91386 Mid Level Clinic Immunologic and V 1.04 $53.48 $10.70 $10.70

Visits. hematologic

diseases.

91388 Mid Level Clinic Malignancy......... V 0.83 $42.68 $8.54 $8.54

Visits.

\1\ 913 Mid Level Clinic Psychiatric V 1.09 $56.05 $14.01 $11.21

91 Visits. disorders.

91397 Mid Level Clinic Infectious disease. V 1.04 $53.48 $10.70 $10.70

Visits.

\4\ 913 Mid Level Clinic Unknown cause of V 1.41 $72.50 $24.86 $14.50

99 Visits. mortality.

\3\ 915 High Level Clinic Well care and V 1.24 $63.76 $15.14 $12.75

11 Visits. administrative.

91518 High Level Clinic Skin and breast V 1.72 $88.44 $19.21 $17.69

Visits. diseases.

91524 High Level Clinic Musculoskeletal V 1.46 $75.07 $15.37 $15.01

Visits. diseases.

91531 High Level Clinic Ear, nose, mouth V 1.35 $69.42 $14.24 $13.88

Visits. and throat

diseases.

91533 High Level Clinic Respiratory system V 1.44 $74.04 $14.81 $14.81

Visits. diseases.

91536 High Level Clinic Cardiovascular V 1.46 $75.07 $15.37 $15.01

Visits. system diseases.

91541 High Level Clinic Digestive system V 1.54 $79.19 $15.84 $15.84

Visits. diseases.

91553 High Level Clinic Kidney, urinary V 1.44 $74.04 $14.81 $14.81

Visits. tract and male

genital diseases.

91556 High Level Clinic Female genital V 1.44 $74.04 $15.14 $14.81

Visits. system diseases.

91557 High Level Clinic Pregnancy and V 1.76 $90.50 $22.83 $18.10

Visits. neonatal care.

91563 High Level Clinic Nervous system V 1.50 $77.13 $16.05 $15.43

Visits. diseases.

91568 High Level Clinic Eye diseases....... V 1.33 $68.39 $13.79 $13.68

Visits.

91572 High Level Clinic Trauma and V 1.72 $88.44 $22.15 $17.69

Visits. poisoning.

91578 High Level Clinic Major signs, V 1.89 $97.18 $29.15 $19.44

Visits. symptoms and

findings.

91582 High Level Clinic Endocrine, V 1.46 $75.07 $15.14 $15.01

Visits. nutritional and

metabolic diseases.

91586 High Level Clinic Immunologic and V 1.76 $90.50 $19.21 $18.10

Visits. hematologic

diseases.

91588 High Level Clinic Malignancy......... V 1.19 $61.19 $12.88 $12.24

Visits.

[[Page 35270]]

\2\ 915 High Level Clinic Psychiatric V 1.63 $83.81 $21.47 $16.76

91 Visits. disorders.

91597 High Level Clinic Infectious disease. V 1.76 $90.50 $19.66 $18.10

Visits.

\4\ 915 High Level Clinic Unknown cause of V 1.41 $72.50 $24.86 $14.50

99 Visits. mortality.

919 Electroconvulsive ................... S 3.09 $158.89 $80.00 $31.78

Therapy.

920 Biofeedback and ................... S 1.17 $60.16 $29.61 $12.03

other Training.

\5\ 921 Diabetes Education. ................... S ......... ......... ........... ...........

926 Dialysis for other ................... S 4.22 $216.99 $69.83 $43.40

than ESRD patients.

928 Alimentary Tests... ................... X 2.91 $149.63 $79.78 $29.93

930 Minor Eye ................... X 1.04 $53.48 $22.83 $10.70

Examinations.

931 Level I Eye Tests.. ................... X 0.74 $38.05 $21.47 $7.61

932 Level II Eye Tests. ................... X 2.41 $123.92 $63.73 $24.78

936 Fitting of Vision ................... X 0.48 $24.68 $9.49 $4.94

Aids.

940 Otorhinolaryngologi ................... X 3.13 $160.94 $52.21 $32.19

c Function Tests.

941 Level I Audiometry. ................... X 0.74 $38.05 $13.33 $7.61

942 Level II Audiometry ................... X 1.46 $75.07 $22.15 $15.01

947 Resuscitation and ................... S 4.11 $211.34 $106.22 $42.27

Cardioversion.

948 Cardiac ................... X 0.81 $41.65 $16.95 $8.33

Rehabilitation.

949 Cardiovascular ................... X 1.43 $73.53 $61.92 $14.71

Stress Test.

950 Electrocardiogram ................... X 0.35 $18.00 $15.82 $3.60

(ECG).

\3\ 951 Low Level ER Visits Well care and V 1.24 $63.76 $15.14 $12.75

11 administrative.

95118 Low Level ER Visits Skin and breast V 1.17 $60.16 $19.21 $12.03

diseases.

95124 Low Level ER Visits Musculoskeletal V 1.17 $60.16 $20.11 $12.03

diseases.

95131 Low Level ER Visits Ear, nose, mouth V 1.11 $57.08 $17.63 $11.42

and throat

diseases.

95133 Low Level ER Visits Respiratory system V 1.15 $59.13 $18.53 $11.83

diseases.

95136 Low Level ER Visits Cardiovascular V 1.26 $64.79 $19.89 $12.96

system diseases.

95141 Low Level ER Visits Digestive system V 1.30 $66.85 $21.02 $13.37

diseases.

95153 Low Level ER Visits Kidney, urinary V 1.43 $73.53 $24.86 $14.71

tract and male

genital diseases.

95156 Low Level ER Visits Female genital V 1.41 $72.50 $23.96 $14.50

system diseases.

95157 Low Level ER Visits Pregnancy and V 1.46 $75.07 $24.63 $15.01

neonatal care.

95163 Low Level ER Visits Nervous system V 1.30 $66.85 $22.60 $13.37

diseases.

95168 Low Level ER Visits Eye diseases....... V 1.20 $61.70 $20.79 $12.34

95172 Low Level ER Visits Trauma and V 1.28 $65.82 $22.15 $13.16

poisoning.

95178 Low Level ER Visits Major signs, V 1.94 $99.75 $36.39 $19.95

symptoms and

findings.

95182 Low Level ER Visits Endocrine, V 1.50 $77.13 $24.63 $15.43

nutritional and

metabolic diseases.

95186 Low Level ER Visits Immunologic and V 1.46 $75.07 $26.89 $15.01

hematologic

diseases.

95188 Low Level ER Visits Malignancy......... V 1.57 $80.73 $27.35 $16.15

\1\ 951 Low Level ER Visits Psychiatric V 1.09 $56.05 $14.01 $11.21

91 Disorders.

95197 Low Level ER Visits Infectious disease. V 1.24 $63.76 $20.57 $12.75

\4\ 951 Low Level ER Visits Unknown cause of V 1.41 $72.50 $24.86 $14.50

99 mortality.

\3\ 953 Mid Level ER Visits Well care and V 1.24 $63.76 $15.14 $12.75

11 administrative.

95318 Mid Level ER Visits Skin and breast V 1.89 $97.18 $34.80 $19.44

diseases.

95324 Mid Level ER Visits Musculoskeletal V 1.78 $91.53 $32.32 $18.31

diseases.

95331 Mid Level ER Visits Ear, nose, mouth V 1.80 $92.56 $31.64 $18.51

and throat

diseases.

95333 Mid Level ER Visits Respiratory system V 1.91 $98.21 $33.67 $19.64

diseases.

95336 Mid Level ER Visits Cardiovascular V 2.02 $103.87 $36.16 $20.77

system diseases.

95341 Mid Level ER Visits Digestive system V 2.02 $103.87 $36.61 $20.77

diseases.

95353 Mid Level ER Visits Kidney, urinary V 2.06 $105.93 $38.65 $21.19

tract and male

genital diseases.

95356 Mid Level ER Visits Female genital V 2.06 $105.93 $36.84 $21.19

system diseases.

95357 Mid Level ER Visits Pregnancy and V 2.10 $107.98 $40.68 $21.60

neonatal care.

95363 Mid Level ER Visits Nervous system V 1.89 $97.18 $35.03 $19.44

diseases.

95368 Mid Level ER Visits Eye diseases....... V 1.67 $85.87 $33.00 $17.17

95372 Mid Level ER Visits Trauma and V 2.02 $103.87 $39.10 $20.77

poisoning.

95378 Mid Level ER Visits Major signs, V 3.07 $157.86 $58.76 $31.57

symptoms and

findings.

95382 Mid Level ER Visits Endocrine, V 2.30 $118.27 $43.84 $23.65

nutritional and

metabolic diseases.

95386 Mid Level ER Visits Immunologic and V 2.48 $127.52 $49.27 $25.50

hematologic

diseases.

95388 Mid Level ER Visits Malignancy......... V 2.17 $111.58 $42.26 $22.32

95391 Mid Level ER Visits Psychiatric V 2.02 $103.87 $35.93 $20.77

Disorders.

95397 Mid Level ER Visits Infectious disease. V 1.99 $102.33 $36.61 $20.47

\4\ 953 Mid Level ER Visits Unknown cause of V 1.41 $72.50 $24.86 $14.50

99 mortality.

\3\ 955 High Level ER Well care and V 1.24 $63.76 $15.14 $12.75

11 Visits. administrative.

95518 High Level ER Skin and breast V 2.59 $133.18 $46.78 $26.64

Visits. diseases.

95524 High Level ER Musculoskeletal V 2.46 $126.49 $41.36 $25.30

Visits. diseases.

95531 High Level ER Ear, nose, mouth V 2.57 $132.15 $44.07 $26.43

Visits. and throat

diseases.

95533 High Level ER Respiratory system V 3.13 $160.94 $54.69 $32.19

Visits. diseases.

95536 High Level ER Cardiovascular V 3.13 $160.94 $54.69 $32.19

Visits. system diseases.

95541 High Level ER Digestive system V 2.89 $148.60 $54.69 $29.72

Visits. diseases.

95553 High Level ER Kidney, urinary V 2.87 $147.58 $54.69 $29.52

Visits. tract and male

genital diseases.

95556 High Level ER Female genital V 2.70 $138.83 $51.08 $27.77

Visits. system diseases.

95557 High Level ER Pregnancy and V 2.89 $148.60 $54.92 $29.72

Visits. neonatal care.

95563 High Level ER Nervous system V 2.74 $140.89 $52.43 $28.18

Visits. diseases.

95568 High Level ER Eye diseases....... V 2.33 $119.81 $40.23 $23.96

Visits.

95572 High Level ER Trauma and V 2.72 $139.86 $50.17 $27.97

Visits. poisoning.

95578 High Level ER Major signs, V 6.83 $351.20 $148.48 $70.24

Visits. symptoms and

findings.

[[Page 35271]]

95582 High Level ER Endocrine, V 3.26 $167.63 $64.86 $33.53

Visits. nutritional and

metabolic diseases.

95586 High Level ER Immunologic and V 3.89 $200.02 $81.81 $40.00

Visits. hematologic

diseases.

95588 High Level ER Malignancy......... V 3.63 $186.65 $68.48 $37.33

Visits.

95591 High Level ER Psychiatric V 3.48 $178.94 $62.60 $35.79

Visits. Disorders.

95597 High Level ER Infectious disease. V 2.78 $142.95 $53.11 $28.59

Visits.

\4\ 955 High Level ER Unknown cause of V 1.41 $72.50 $24.86 $14.50

99 Visits. mortality.

956 Continuous ECG and ................... X 1.09 $56.05 $54.47 $11.21

Blood Pressure

Monitoring.

957 Echocardiography... ................... S 4.04 $207.74 $114.13 $41.55

958 Diagnostic Cardiac ................... S 23.74 $1,220.71 $705.57 $244.14

Catheterization.

960 Cardiac ................... S 4.80 $246.82 $143.74 $49.36

Electrophysiologic

Tests/Procedures.

966 Electronic Analysis ................... X 0.39 $20.05 $12.43 $4.01

of Pacemakers/

other Devices.

967 Non-Invasive ................... X 1.70 $87.41 $57.40 $17.48

Vascular Studies.

968 Vascular Ultrasound ................... X 2.39 $122.89 $79.55 $24.58

969 Hyperbaric Oxygen.. ................... S 2.65 $136.26 $141.70 $27.25

971 Level I Pulmonary ................... X 0.98 $50.39 $26.44 $10.08

Tests.

972 Level II Pulmonary ................... X 1.00 $51.42 $29.38 $10.28

Tests.

973 Level III Pulmonary ................... S 1.81 $93.07 $55.82 $18.61

Tests.

976 Pulmonary Therapy.. ................... S 0.44 $22.62 $14.69 $4.53

977 Allergy Tests...... ................... X 0.56 $28.80 $11.30 $5.76

978 Allergy Injections. ................... X 0.30 $15.43 $3.39 $3.09

979 Extended EEG ................... S 10.15 $521.91 $287.25 $104.38

Studies and Sleep

Studies.

980 Electroencephalogra ................... S 2.15 $110.55 $57.86 $22.11

m.

981 Level I Nerve and ................... X 1.22 $62.73 $34.35 $12.55

Muscle Tests.

982 Level II Nerve and ................... X 1.37 $70.45 $38.42 $14.09

Muscle Tests.

987 Subcutaneous or ................... S 2.09 $107.47 $65.09 $21.49

Intramuscular

Chemotherapy.

988 Chemotherapy except ................... S 4.02 $206.71 $110.29 $41.34

by Extended

Infusion.

989 Chemotherapy by ................... S 1.91 $98.21 $44.52 $19.64

Extended Infusion.

990 Photochemotherapy.. ................... S 0.43 $22.11 $8.14 $4.42

997 Manipulation ................... S 0.69 $35.48 $7.46 $7.10

Therapy.

999 Therapeutic ................... X 0.43 $22.11 $11.07 $4.42

Phlebotomy.

----------------------------------------------------------------------------------------------------------------

Notes:

\1\ Median costs APCs 091, 91191, 91391, 95191 computed together because there is no differences in facility

resources.

\2\ Median costs APCs 092 and 91591 computed together because there is no differences in facility resources.

\3\ Median costs for all claims in combined visit levels for MDC 11; one rate is paid for multiple levels.

\4\ Median costs for all claims in combined visit levels for MDC 99; one rate is paid for multiple levels.

\5\ APCs 317 and 921 have anomalous weights. Refer to preamble for discussion.

\6\ This APC reflects the per-diem payment for patients recieving services under a partial hospitalization

program.

\7\ The national unadjusted coinsurance amount is subtracted from the proposed payment rate to determine the

amount Medicare pays.

47. On pages 47621 through 47761, Addendum B is corrected to read

as follows:

CPT codes and descriptions only are

copyright 1997 American Medical Association. All rights reserved.

Applicable FARS/DFARS apply.

Copyright 1994 American Dental Association. All rights reserved.

[[Page 35271]]

Addendum B.--Proposed Hospital Outpatient Department (HOPD) Payment Status by HCPCS Code and Related Information

----------------------------------------------------------------------------------------------------------------

Proposed National Minimum

CPT/ HOPD status Description Proposed Relative payment unadjusted unadjusted

HCPCS indicator APC weight rate coinsurance coinsurance

----------------------------------------------------------------------------------------------------------------

00100 N Anesth, skin surgery... ......... ......... ......... ........... ...........

00102 N Anesth, repair of cleft ......... ......... ......... ........... ...........

lip.

00103 N Anesth, blepharoplasty. ......... ......... ......... ........... ...........

00104 N Anesth for electroshock ......... ......... ......... ........... ...........

00120 N Anesthesia for ear ......... ......... ......... ........... ...........

surgery.

00124 N Anesthesia for ear exam ......... ......... ......... ........... ...........

00126 N Anesth, tympanotomy.... ......... ......... ......... ........... ...........

00140 N Anesth, procedures on ......... ......... ......... ........... ...........

eye.

00142 N Anesthesia for lens ......... ......... ......... ........... ...........

surgery.

00144 N Anesth, corneal ......... ......... ......... ........... ...........

transplant.

00145 N Anesth, vitrectomy..... ......... ......... ......... ........... ...........

00147 N Anesth, iridectomy..... ......... ......... ......... ........... ...........

00148 N Anesthesia for eye exam ......... ......... ......... ........... ...........

00160 N Anesth, nose, sinus ......... ......... ......... ........... ...........

surgery.

00162 N Anesth, nose, sinus ......... ......... ......... ........... ...........

surgery.

00164 N Anesth, biopsy of nose. ......... ......... ......... ........... ...........

00170 N Anesth, procedure on ......... ......... ......... ........... ...........

mouth.

00172 N Anesth, cleft palate ......... ......... ......... ........... ...........

repair.

00174 C Anesth, pharyngeal ......... ......... ......... ........... ...........

surgery.

00176 C Anesth, pharyngeal ......... ......... ......... ........... ...........

surgery.

[[Page 35272]]

00190 N Anesth, facial bone ......... ......... ......... ........... ...........

surgery.

00192 C Anesth, facial bone ......... ......... ......... ........... ...........

surgery.

00210 N Anesth, open head ......... ......... ......... ........... ...........

surgery.

00212 N Anesth, skull drainage. ......... ......... ......... ........... ...........

00214 C Anesth, skull drainage. ......... ......... ......... ........... ...........

00215 C Anesth, skull fracture. ......... ......... ......... ........... ...........

00216 N Anesth, head vessel ......... ......... ......... ........... ...........

surgery.

00218 N Anesth, special head ......... ......... ......... ........... ...........

surgery.

00220 N Anesth, spinal fluid ......... ......... ......... ........... ...........

shunt.

00222 N Anesth, head nerve ......... ......... ......... ........... ...........

surgery.

00300 N Anesth, skin surgery, ......... ......... ......... ........... ...........

neck.

00320 N Anesth, neck organ ......... ......... ......... ........... ...........

surgery.

00322 N Anesth, biopsy of ......... ......... ......... ........... ...........

thyroid.

00350 N Anesth, neck vessel ......... ......... ......... ........... ...........

surgery.

00352 N Anesth, neck vessel ......... ......... ......... ........... ...........

surgery.

00400 N Anesth, chest skin ......... ......... ......... ........... ...........

surgery.

00402 N Anesth, surgery of ......... ......... ......... ........... ...........

breast.

00404 C Anesth, surgery of ......... ......... ......... ........... ...........

breast.

00406 C Anesth, surgery of ......... ......... ......... ........... ...........

breast.

00410 N Anesth, correct heart ......... ......... ......... ........... ...........

rhythm.

00420 N Anesth, skin surgery, ......... ......... ......... ........... ...........

back.

00450 N Anesth, surgery of ......... ......... ......... ........... ...........

shoulder.

00452 C Anesth, surgery of ......... ......... ......... ........... ...........

shoulder.

00454 N Anesth, collar bone ......... ......... ......... ........... ...........

biopsy.

00470 N Anesth, removal of rib. ......... ......... ......... ........... ...........

00472 N Anesth, chest wall ......... ......... ......... ........... ...........

repair.

00474 C Anesth, surgery of ......... ......... ......... ........... ...........

rib(s).

00500 N Anesth, esophageal ......... ......... ......... ........... ...........

surgery.

00520 N Anesth, chest procedure ......... ......... ......... ........... ...........

00522 N Anesth, chest lining ......... ......... ......... ........... ...........

biopsy.

00524 C Anesth, chest drainage. ......... ......... ......... ........... ...........

00528 N Anesth, chest partition ......... ......... ......... ........... ...........

view.

00530 C Anesth, pacemaker ......... ......... ......... ........... ...........

insertion.

00532 N Anesth, vascular access ......... ......... ......... ........... ...........

00534 N Anesth, cardioverter/ ......... ......... ......... ........... ...........

defib.

00540 C Anesth, chest surgery.. ......... ......... ......... ........... ...........

00542 C Anesth, release of lung ......... ......... ......... ........... ...........

00544 C Anesth, chest lining ......... ......... ......... ........... ...........

removal.

00546 C Anesth, lung,chest wall ......... ......... ......... ........... ...........

surg.

00548 N Anesth, trachea,bronchi ......... ......... ......... ........... ...........

surg.

00560 C Anesth, open heart ......... ......... ......... ........... ...........

surgery.

00562 C Anesth, open heart ......... ......... ......... ........... ...........

surgery.

00580 C Anesth,heart/lung ......... ......... ......... ........... ...........

transplant.

00600 N Anesth, spine, cord ......... ......... ......... ........... ...........

surgery.

00604 C Anesth, surgery of ......... ......... ......... ........... ...........

vertebra.

00620 N Anesth, spine, cord ......... ......... ......... ........... ...........

surgery.

00622 C Anesth, removal of ......... ......... ......... ........... ...........

nerves.

00630 N Anesth, spine, cord ......... ......... ......... ........... ...........

surgery.

00632 C Anesth, removal of ......... ......... ......... ........... ...........

nerves.

00634 C Anesth for ......... ......... ......... ........... ...........

chemonucleolysis.

00670 C Anesth, spine, cord ......... ......... ......... ........... ...........

surgery.

00700 N Anesth, abdominal wall ......... ......... ......... ........... ...........

surg.

00702 N Anesth, for liver ......... ......... ......... ........... ...........

biopsy.

00730 N Anesth, abdominal wall ......... ......... ......... ........... ...........

surg.

00740 N Anesth, gi ......... ......... ......... ........... ...........

visualization.

00750 N Anesth, repair of ......... ......... ......... ........... ...........

hernia.

00752 N Anesth, repair of ......... ......... ......... ........... ...........

hernia.

00754 N Anesth, repair of ......... ......... ......... ........... ...........

hernia.

00756 N Anesth, repair of ......... ......... ......... ........... ...........

hernia.

00770 N Anesth, blood vessel ......... ......... ......... ........... ...........

repair.

00790 N Anesth, surg upper ......... ......... ......... ........... ...........

abdomen.

00792 C Anesth, part liver ......... ......... ......... ........... ...........

removal.

00794 C Anesth, pancreas ......... ......... ......... ........... ...........

removal.

00796 C Anesth, for liver ......... ......... ......... ........... ...........

transplant.

00800 N Anesth, abdominal wall ......... ......... ......... ........... ...........

surg.

00802 C Anesth, fat layer ......... ......... ......... ........... ...........

removal.

00810 N Anesth, intestine ......... ......... ......... ........... ...........

endoscopy.

00820 N Anesth, abdominal wall ......... ......... ......... ........... ...........

surg.

00830 N Anesth, repair of ......... ......... ......... ........... ...........

hernia.

00832 N Anesth, repair of ......... ......... ......... ........... ...........

hernia.

00840 N Anesth, surg lower ......... ......... ......... ........... ...........

abdomen.

00842 N Anesth, amniocentesis.. ......... ......... ......... ........... ...........

00844 C Anesth, pelvis surgery. ......... ......... ......... ........... ...........

00846 C Anesth, hysterectomy... ......... ......... ......... ........... ...........

00848 C Anesth, pelvic organ ......... ......... ......... ........... ...........

surg.

[[Page 35273]]

00850 C Anesth, cesarean ......... ......... ......... ........... ...........

section.

00855 C Anesth, hysterectomy... ......... ......... ......... ........... ...........

00857 C Analgesia, labor & c- ......... ......... ......... ........... ...........

section.

00860 N Anesth, surgery of ......... ......... ......... ........... ...........

abdomen.

00862 N Anesth, kidney, ureter ......... ......... ......... ........... ...........

surg.

00864 C Anesth, removal of ......... ......... ......... ........... ...........

bladder.

00865 C Anesth, removal of ......... ......... ......... ........... ...........

prostate.

00866 C Anesth, removal of ......... ......... ......... ........... ...........

adrenal.

00868 C Anesth, kidney ......... ......... ......... ........... ...........

transplant.

00870 N Anesth, bladder stone ......... ......... ......... ........... ...........

surg.

00872 N Anesth,kidney stone ......... ......... ......... ........... ...........

destruct.

00873 N Anesth,kidney stone ......... ......... ......... ........... ...........

destruct.

00880 N Anesth, abdomen vessel ......... ......... ......... ........... ...........

surg.

00882 C Anesth, major vein ......... ......... ......... ........... ...........

ligation.

00884 C Anesth, major vein ......... ......... ......... ........... ...........

revision.

00900 N Anesth, perineal ......... ......... ......... ........... ...........

procedure.

00902 N Anesth, anorectal ......... ......... ......... ........... ...........

surgery.

00904 C Anesth, perineal ......... ......... ......... ........... ...........

surgery.

00906 N Anesth, removal of ......... ......... ......... ........... ...........

vulva.

00908 C Anesth, removal of ......... ......... ......... ........... ...........

prostate.

00910 N Anesth, bladder surgery ......... ......... ......... ........... ...........

00912 N Anesth, bladder tumor ......... ......... ......... ........... ...........

surg.

00914 N Anesth, removal of ......... ......... ......... ........... ...........

prostate.

00916 N Anesth, bleeding ......... ......... ......... ........... ...........

control.

00918 N Anesth, stone removal.. ......... ......... ......... ........... ...........

00920 N Anesth, genitalia ......... ......... ......... ........... ...........

surgery.

00922 N Anesth, sperm duct ......... ......... ......... ........... ...........

surgery.

00924 N Anesth, testis ......... ......... ......... ........... ...........

exploration.

00926 N Anesth, removal of ......... ......... ......... ........... ...........

testis.

00928 C Anesth, removal of ......... ......... ......... ........... ...........

testis.

00930 N Anesth, testis ......... ......... ......... ........... ...........

suspension.

00932 C Anesth, amputation of ......... ......... ......... ........... ...........

penis.

00934 C Anesth, penis, nodes ......... ......... ......... ........... ...........

removal.

00936 C Anesth, penis, nodes ......... ......... ......... ........... ...........

removal.

00938 N Anesth, insert penis ......... ......... ......... ........... ...........

device.

00940 N Anesth, vaginal ......... ......... ......... ........... ...........

procedures.

00942 N Anesth, surgery on ......... ......... ......... ........... ...........

vagina.

00944 C Anesth, vaginal ......... ......... ......... ........... ...........

hysterectomy.

00946 N Anesth, vaginal ......... ......... ......... ........... ...........

delivery.

00948 N Anesth, repair of ......... ......... ......... ........... ...........

cervix.

00950 N Anesth, vaginal ......... ......... ......... ........... ...........

endoscopy.

00952 N Anesth, uterine ......... ......... ......... ........... ...........

endoscopy.

00955 C Analgesia, vaginal ......... ......... ......... ........... ...........

delivery.

01000 N Anesth, skin surgery, ......... ......... ......... ........... ...........

pelvis.

01110 N Anesth, skin surgery, ......... ......... ......... ........... ...........

pelvis.

01120 N Anesth, pelvis surgery. ......... ......... ......... ........... ...........

01130 N Anesth, body cast ......... ......... ......... ........... ...........

procedure.

01140 C Anesth, amputation at ......... ......... ......... ........... ...........

pelvis.

01150 C Anesth, pelvic tumor ......... ......... ......... ........... ...........

surgery.

01160 N Anesth, pelvis ......... ......... ......... ........... ...........

procedure.

01170 N Anesth, pelvis surgery. ......... ......... ......... ........... ...........

01180 N Anesth, pelvis nerve ......... ......... ......... ........... ...........

removal.

01190 C Anesth, pelvis nerve ......... ......... ......... ........... ...........

removal.

01200 N Anesth, hip joint ......... ......... ......... ........... ...........

procedure.

01202 N Anesth, arthroscopy of ......... ......... ......... ........... ...........

hip.

01210 N Anesth, hip joint ......... ......... ......... ........... ...........

surgery.

01212 C Anesth, hip ......... ......... ......... ........... ...........

disarticulation.

01214 C Anesth, replacement of ......... ......... ......... ........... ...........

hip.

01220 N Anesth, procedure on ......... ......... ......... ........... ...........

femur.

01230 N Anesth, surgery of ......... ......... ......... ........... ...........

femur.

01232 C Anesth, amputation of ......... ......... ......... ........... ...........

femur.

01234 C Anesth, radical femur ......... ......... ......... ........... ...........

surg.

01240 N Anesth, upper leg skin ......... ......... ......... ........... ...........

surg.

01250 N Anesth, upper leg ......... ......... ......... ........... ...........

surgery.

01260 N Anesth, upper leg veins ......... ......... ......... ........... ...........

surg.

01270 N Anesth, thigh arteries ......... ......... ......... ........... ...........

surg.

01272 C Anesth, femoral artery ......... ......... ......... ........... ...........

surg.

01274 C Anesth, femoral ......... ......... ......... ........... ...........

embolectomy.

01300 N Anesth, skin surgery, ......... ......... ......... ........... ...........

knee.

01320 N Anesth, knee area ......... ......... ......... ........... ...........

surgery.

01340 N Anesth, knee area ......... ......... ......... ........... ...........

procedure.

01360 N Anesth, knee area ......... ......... ......... ........... ...........

surgery.

01380 N Anesth, knee joint ......... ......... ......... ........... ...........

procedure.

01382 N Anesth, knee ......... ......... ......... ........... ...........

arthroscopy.

01390 N Anesth, knee area ......... ......... ......... ........... ...........

procedure.

[[Page 35274]]

01392 N Anesth, knee area ......... ......... ......... ........... ...........

surgery.

01400 N Anesth, knee joint ......... ......... ......... ........... ...........

surgery.

01402 C Anesth, replacement of ......... ......... ......... ........... ...........

knee.

01404 C Anesth, amputation at ......... ......... ......... ........... ...........

knee.

01420 N Anesth, knee joint ......... ......... ......... ........... ...........

casting.

01430 N Anesth, knee veins ......... ......... ......... ........... ...........

surgery.

01432 N Anesth, knee vessel ......... ......... ......... ........... ...........

surg.

01440 N Anesth, knee arteries ......... ......... ......... ........... ...........

surg.

01442 C Anesth, knee artery ......... ......... ......... ........... ...........

surg.

01444 C Anesth, knee artery ......... ......... ......... ........... ...........

repair.

01460 N Anesth, lower leg skin ......... ......... ......... ........... ...........

surg.

01462 N Anesth, lower leg ......... ......... ......... ........... ...........

procedure.

01464 N Anesth, ankle ......... ......... ......... ........... ...........

arthroscopy.

01470 N Anesth, lower leg ......... ......... ......... ........... ...........

surgery.

01472 N Anesth, achilles tendon ......... ......... ......... ........... ...........

surg.

01474 N Anesth, lower leg ......... ......... ......... ........... ...........

surgery.

01480 N Anesth, lower leg bone ......... ......... ......... ........... ...........

surg.

01482 N Anesth, radical leg ......... ......... ......... ........... ...........

surgery.

01484 N Anesth, lower leg ......... ......... ......... ........... ...........

revision.

01486 C Anesth, ankle ......... ......... ......... ........... ...........

replacement.

01490 N Anesth, lower leg ......... ......... ......... ........... ...........

casting.

01500 N Anesth, leg arteries ......... ......... ......... ........... ...........

surg.

01502 C Anesth, lowerleg ......... ......... ......... ........... ...........

embolectomy.

01520 N Anesth, lower leg vein ......... ......... ......... ........... ...........

surg.

01522 N Anesth, lower leg vein ......... ......... ......... ........... ...........

surg.

01600 N Anesth, shoulder skin ......... ......... ......... ........... ...........

surg.

01610 N Anesth, surgery of ......... ......... ......... ........... ...........

shoulder.

01620 N Anesth, shoulder ......... ......... ......... ........... ...........

procedure.

01622 N Anesth, shoulder ......... ......... ......... ........... ...........

arthroscopy.

01630 N Anesth, surgery of ......... ......... ......... ........... ...........

shoulder.

01632 C Anesth, surgery of ......... ......... ......... ........... ...........

shoulder.

01634 C Anesth, shoulder joint ......... ......... ......... ........... ...........

amput.

01636 C Anesth, forequarter ......... ......... ......... ........... ...........

amput.

01638 C Anesth, shoulder ......... ......... ......... ........... ...........

replacement.

01650 N Anesth, shoulder artery ......... ......... ......... ........... ...........

surg.

01652 C Anesth, shoulder vessel ......... ......... ......... ........... ...........

surg.

01654 C Anesth, shoulder vessel ......... ......... ......... ........... ...........

surg.

01656 C Anesth, arm-leg vessel ......... ......... ......... ........... ...........

surg.

01670 N Anesth, shoulder vein ......... ......... ......... ........... ...........

surg.

01680 N Anesth, shoulder ......... ......... ......... ........... ...........

casting.

01682 N Anesth, airplane cast.. ......... ......... ......... ........... ...........

01700 N Anesth, elbow area skin ......... ......... ......... ........... ...........

surg.

01710 N Anesth, elbow area ......... ......... ......... ........... ...........

surgery.

01712 N Anesth, upperarm tendon ......... ......... ......... ........... ...........

surg.

01714 N Anesth, upperarm tendon ......... ......... ......... ........... ...........

surg.

01716 N Anesth, biceps tendon ......... ......... ......... ........... ...........

repair.

01730 N Anesth, upperarm ......... ......... ......... ........... ...........

procedure.

01732 N Anesth, elbow ......... ......... ......... ........... ...........

arthroscopy.

01740 N Anesth, upper arm ......... ......... ......... ........... ...........

surgery.

01742 N Anesth, humerus surgery ......... ......... ......... ........... ...........

01744 N Anesth, humerus repair. ......... ......... ......... ........... ...........

01756 C Anesth, radical humerus ......... ......... ......... ........... ...........

surg.

01758 N Anesth, humeral lesion ......... ......... ......... ........... ...........

surg.

01760 N Anesth, elbow ......... ......... ......... ........... ...........

replacement.

01770 N Anesth, upperarm artery ......... ......... ......... ........... ...........

surg.

01772 C Anesth, upperarm ......... ......... ......... ........... ...........

embolectomy.

01780 N Anesth, upper arm vein ......... ......... ......... ........... ...........

surg.

01782 C Anesth, upperarm vein ......... ......... ......... ........... ...........

repair.

01784 N Anesth, av fistula ......... ......... ......... ........... ...........

repair.

01800 N Anesth, lower arm skin ......... ......... ......... ........... ...........

surg.

01810 N Anesth, lower arm ......... ......... ......... ........... ...........

surgery.

01820 N Anesth, lower arm ......... ......... ......... ........... ...........

procedure.

01830 N Anesth, lower arm ......... ......... ......... ........... ...........

surgery.

01832 N Anesth, wrist ......... ......... ......... ........... ...........

replacement.

01840 N Anesth, lowerarm artery ......... ......... ......... ........... ...........

surg.

01842 C Anesth, lowerarm ......... ......... ......... ........... ...........

embolectomy.

01844 N Anesth, vascular shunt ......... ......... ......... ........... ...........

surg.

01850 N Anesth, lower arm vein ......... ......... ......... ........... ...........

surg.

01852 C Anesth, lowerarm vein ......... ......... ......... ........... ...........

repair.

01860 N Anesth, lower arm ......... ......... ......... ........... ...........

casting.

01900 N Anesth, uterus/tube ......... ......... ......... ........... ...........

inject.

01902 C Anesth, burr holes, ......... ......... ......... ........... ...........

skull.

01904 C Anesth, skull x-ray ......... ......... ......... ........... ...........

inject.

01906 N Anesth, lumbar ......... ......... ......... ........... ...........

myelography.

01908 N Anesth, cervical ......... ......... ......... ........... ...........

myelography.

[[Page 35275]]

01910 N Anesth, skull ......... ......... ......... ........... ...........

myelography.

01912 N Anesth, lumbar ......... ......... ......... ........... ...........

discography.

01914 N Anesth, cervical ......... ......... ......... ........... ...........

discography.

01916 C Anesth, head ......... ......... ......... ........... ...........

arteriogram.

01918 C Anesth, limb ......... ......... ......... ........... ...........

arteriogram.

01920 N Anesth, catheterize ......... ......... ......... ........... ...........

heart.

01921 C Anesth, vessel surgery. ......... ......... ......... ........... ...........

01922 N Anesth, cat or MRI scan ......... ......... ......... ........... ...........

01990 C Support for organ donor ......... ......... ......... ........... ...........

01995 N Regional anesthesia, ......... ......... ......... ........... ...........

limb.

01996 N Manage daily drug ......... ......... ......... ........... ...........

therapy.

01999 N Unlisted anesth ......... ......... ......... ........... ...........

procedure.

10040 T Acne surgery of skin 131 1.93 $99.24 $36.61 $19.85

abscess.

10060 T Drainage of skin 131 1.93 $99.24 $36.61 $19.85

abscess.

10061 T Drainage of skin 131 1.93 $99.24 $36.61 $19.85

abscess.

10080 T Drainage of pilonidal 131 1.93 $99.24 $36.61 $19.85

cyst.

10081 T Drainage of pilonidal 131 1.93 $99.24 $36.61 $19.85

cyst.

10120 T Remove foreign body.... 131 1.93 $99.24 $36.61 $19.85

10121 T Remove foreign body.... 163 10.48 $538.88 $260.80 $107.78

10140 T Drainage of hematoma/ 131 1.93 $99.24 $36.61 $19.85

fluid.

10160 T Puncture drainage of 131 1.93 $99.24 $36.61 $19.85

lesion.

10180 T Complex drainage, wound 131 1.93 $99.24 $36.61 $19.85

11000 T Debride infected skin.. 151 1.63 $83.81 $33.22 $16.76

11001 T Debride infect skin add- 151 1.63 $83.81 $33.22 $16.76

on.

11010 T Debride skin, fx....... 163 10.48 $538.88 $260.80 $107.78

11011 T Debride skin/muscle, fx 163 10.48 $538.88 $260.80 $107.78

11012 T Debride skin/muscle/ 163 10.48 $538.88 $260.80 $107.78

bone, fx.

11040 T Debride skin partial... 151 1.63 $83.81 $33.22 $16.76

11041 T Debride skin full...... 151 1.63 $83.81 $33.22 $16.76

11042 T Debride skin/tissue.... 151 1.63 $83.81 $33.22 $16.76

11043 T Debride tissue/muscle.. 162 5.59 $287.44 $125.66 $57.49

11044 T Debride tissue/muscle/ 162 5.59 $287.44 $125.66 $57.49

bone.

\2\ 1105 T Trim skin lesion....... 151 1.63 $83.81 $33.22 $16.76

0

\2\ 1105 T Trim 2 to 4 skin 151 1.63 $83.81 $33.22 $16.76

1 lesions.

\2\ 1105 T Trim over 4 skin 151 1.63 $83.81 $33.22 $16.76

2 lesions.

11055 T Trim skin lesion....... 151 1.63 $83.81 $33.22 $16.76

11056 T Trim 2 to 4 skin 151 1.63 $83.81 $33.22 $16.76

lesions.

11057 T Trim over 4 skin 151 1.63 $83.81 $33.22 $16.76

lesions.

11100 T Biopsy of skin lesion.. 161 3.43 $176.37 $75.71 $35.27

11101 T Biopsy, skin add-on.... 161 3.43 $176.37 $75.71 $35.27

11200 T Removal of skin tags... 151 1.63 $83.81 $33.22 $16.76

11201 T Remove skin tags add-on 151 1.63 $83.81 $33.22 $16.76

11300 T Shave skin lesion...... 151 1.63 $83.81 $33.22 $16.76

11301 T Shave skin lesion...... 151 1.63 $83.81 $33.22 $16.76

11302 T Shave skin lesion...... 151 1.63 $83.81 $33.22 $16.76

11303 T Shave skin lesion...... 151 1.63 $83.81 $33.22 $16.76

11305 T Shave skin lesion...... 151 1.63 $83.81 $33.22 $16.76

11306 T Shave skin lesion...... 151 1.63 $83.81 $33.22 $16.76

11307 T Shave skin lesion...... 151 1.63 $83.81 $33.22 $16.76

11308 T Shave skin lesion...... 151 1.63 $83.81 $33.22 $16.76

11310 T Shave skin lesion...... 151 1.63 $83.81 $33.22 $16.76

11311 T Shave skin lesion...... 151 1.63 $83.81 $33.22 $16.76

11312 T Shave skin lesion...... 151 1.63 $83.81 $33.22 $16.76

11313 T Shave skin lesion...... 151 1.63 $83.81 $33.22 $16.76

11400 T Removal of skin lesion. 161 3.43 $176.37 $75.71 $35.27

11401 T Removal of skin lesion. 161 3.43 $176.37 $75.71 $35.27

11402 T Removal of skin lesion. 161 3.43 $176.37 $75.71 $35.27

11403 T Removal of skin lesion. 161 3.43 $176.37 $75.71 $35.27

11404 T Removal of skin lesion. 162 5.59 $287.44 $125.66 $57.49

11406 T Removal of skin lesion. 163 10.48 $538.88 $260.80 $107.78

11420 T Removal of skin lesion. 161 3.43 $176.37 $75.71 $35.27

11421 T Removal of skin lesion. 161 3.43 $176.37 $75.71 $35.27

11422 T Removal of skin lesion. 161 3.43 $176.37 $75.71 $35.27

11423 T Removal of skin lesion.

This text is long and has been trimmed here. Open the source document for the complete record.

This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.

A word about cookies

We need a few to keep you signed in and the library working. The rest help us see which pages people use and where they get stuck. They stay off unless you say yes.